{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 381744, "items": [{"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T21:40:57Z", "timestamp": 1574458857103}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Endocrinology"], "published-print": {"date-parts": [[2012, 4]]}, "DOI": "10.1210/me.2011-1101", "type": "journal-article", "created": {"date-parts": [[2012, 3, 9]], "date-time": "2012-03-09T02:48:21Z", "timestamp": 1331261301000}, "page": "550-561", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Central Role for PELP1 in Nonandrogenic Activation of the Androgen Receptor in Prostate Cancer"], "prefix": "10.1210", "volume": "26", "author": [{"given": "Lin", "family": "Yang", "sequence": "first", "affiliation": []}, {"given": "Preethi", "family": "Ravindranathan", "sequence": "additional", "affiliation": []}, {"given": "Meera", "family": "Ramanan", "sequence": "additional", "affiliation": []}, {"given": "Payal", "family": "Kapur", "sequence": "additional", "affiliation": []}, {"given": "Stephen R.", "family": "Hammes", "sequence": "additional", "affiliation": []}, {"given": "Jer-Tsong", "family": "Hsieh", "sequence": "additional", "affiliation": []}, {"given": "Ganesh V.", "family": "Raj", "sequence": "additional", "affiliation": []}], "member": "80", "container-title": ["Molecular Endocrinology"], "language": "en", "link": [{"URL": "http://academic.oup.com/mend/article-pdf/26/4/550/8934264/mend0550.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 25]], "date-time": "2017-08-25T03:10:58Z", "timestamp": 1503630658000}, "score": 52.473553, "issued": {"date-parts": [[2012, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 4]]}, "issue": "4"}, "alternative-id": ["10.1210/me.2011-1101"], "URL": "http://dx.doi.org/10.1210/me.2011-1101", "ISSN": ["0888-8809", "1944-9917"], "issn-type": [{"value": "0888-8809", "type": "print"}, {"value": "1944-9917", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:47:35Z", "timestamp": 1574513255796}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4S", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 4, 1]], "date-time": "2011-04-01T00:00:00Z", "timestamp": 1301616000000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "Dorothy and James Cleo Thompson Research Fund", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2011, 4]]}, "DOI": "10.1016/j.juro.2011.02.1369", "type": "journal-article", "created": {"date-parts": [[2011, 5, 20]], "date-time": "2011-05-20T11:16:38Z", "timestamp": 1305890198000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["1456 CENTRAL ROLE FOR PELP1-ANDROGEN RECEPTOR COMPLEX IN PROSTATE CANCER"], "prefix": "10.1097", "volume": "185", "author": [{"given": "Lin", "family": "Yang", "sequence": "first", "affiliation": [{"name": "Dallas, TX"}]}, {"given": "Preethi", "family": "Ravindranath", "sequence": "additional", "affiliation": [{"name": "Dallas, TX"}]}, {"given": "Ganesh", "family": "Raj", "sequence": "additional", "affiliation": [{"name": "Dallas, TX"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S002253471101617X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S002253471101617X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T16:32:41Z", "timestamp": 1560789161000}, "score": 47.86509, "issued": {"date-parts": [[2011, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2011, 4]]}, "issue": "4S"}, "alternative-id": ["10.1016/j.juro.2011.02.1369"], "URL": "http://dx.doi.org/10.1016/j.juro.2011.02.1369", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:34:54Z", "timestamp": 1574296494035}, "publisher-location": "New York, NY", "reference-count": 109, "publisher": "Springer US", "isbn-type": [{"value": "9780387691770", "type": "print"}, {"value": "9780387691794", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-0-387-69179-4_14", "type": "book-chapter", "created": {"date-parts": [[2009, 4, 18]], "date-time": "2009-04-18T16:59:37Z", "timestamp": 1240073977000}, "page": "315-340", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Coregulators and the Regulation of Androgen Receptor Action in Prostate Cancer"], "prefix": "10.1007", "author": [{"given": "Irina U.", "family": "Agoulnik", "sequence": "first", "affiliation": []}, {"given": "Nancy L.", "family": "Weigel", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 3, 27]]}, "reference": [{"key": "14_CR1_14", "doi-asserted-by": "crossref", "first-page": "362", "DOI": "10.1002/jcb.20811", "volume": "99", "author": "I. U. Agoulnik", "year": "2006", "unstructured": "Agoulnik, I. U., and N. L. Weigel. 2006. Androgen receptor action in hormone-dependent and recurrent prostate cancer. J Cell Biochem 99: 362\u201372.", "journal-title": "J Cell Biochem"}, {"key": "14_CR2_14", "doi-asserted-by": "crossref", "first-page": "31136", "DOI": "10.1074/jbc.M305153200", "volume": "278", "author": "I. U. Agoulnik", "year": "2003", "unstructured": "Agoulnik, I. U., W. C. Krause, W. E. Bingman, III, H. T. Rahman, M. Amrikachi, G. E. Ayala, and N. L. Weigel. 2003. Repressors of androgen and progesterone receptor action. J Biol Chem 278: 31136\u201348.", "journal-title": "J Biol Chem"}, {"key": "14_CR3_14", "doi-asserted-by": "crossref", "first-page": "7959", "DOI": "10.1158/0008-5472.CAN-04-3541", "volume": "65", "author": "I. U. Agoulnik", "year": "2005", "unstructured": "Agoulnik, I. U., A. Vaid, W. E. Bingman, III, H. Erdeme, A. Frolov, C. L. Smith, G. Ayala, M. M. Ittmann, and N. L. Weigel. 2005. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res 65: 7959\u201367.", "journal-title": "Cancer Res"}, {"key": "14_CR4_14", "doi-asserted-by": "crossref", "first-page": "10594", "DOI": "10.1158/0008-5472.CAN-06-1023", "volume": "66", "author": "I. U. Agoulnik", "year": "2006", "unstructured": "Agoulnik, I. U., A. Vaid, M. Nakka, M. Alvarado, W. E. Bingman, III, H. Erdem, A. Frolov, C. L. Smith, G. E. Ayala, M. M. Ittmann, and N. L. Weigel. 2006. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res 66: 10594\u2013602.", "journal-title": "Cancer Res"}, {"key": "14_CR5_14", "doi-asserted-by": "crossref", "first-page": "965", "DOI": "10.1126/science.277.5328.965", "volume": "277", "author": "S. L. Anzick", "year": "1997", "unstructured": "Anzick, S. L., J. Kononen, R. L. Walker, D. O. Azorsa, M. M. Tanner, X. Y. Guan, G. Sauter, O. P. Kallioniemi, J. M. Trent, and P. S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965\u20138.", "journal-title": "Science"}, {"key": "14_CR6_14", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1677/erc.0.0090061", "volume": "9", "author": "J. T. Arnold", "year": "2002", "unstructured": "Arnold, J. T., and J. T. Isaacs. 2002. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocr Relat Cancer 9: 61\u201373.", "journal-title": "Endocr Relat Cancer"}, {"key": "14_CR7_14", "first-page": "6244", "volume": "63", "author": "G. Ayala", "year": "2003", "unstructured": "Ayala, G., D. Wang, G. Wulf, A. Frolov, R. Li, J. Sowadski, T. M. Wheeler, K. P. Lu, and L. Bao. 2003. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 63: 6244\u201351.", "journal-title": "Cancer Res"}, {"key": "14_CR8_14", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1002/ijc.22673", "volume": "121", "author": "A. Barrett", "year": "2007", "unstructured": "Barrett, A., S. Santangelo, K. Tan, S. Catchpole, K. Roberts, B. Spencer-Dene, D. Hall, A. Scibetta, J. Burchell, E. Verdin, P. Freemont, and J. Taylor-Papadimitriou. 2007. Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases. Int J Cancer 121: 265\u201375.", "journal-title": "Int J Cancer"}, {"key": "14_CR9_14", "doi-asserted-by": "crossref", "first-page": "37341", "DOI": "10.1074/jbc.M706978200", "volume": "282", "author": "T. Bawa-Khalfe", "year": "2007", "unstructured": "Bawa-Khalfe, T., J. Cheng, Z. Wang, and E. T. Yeh. 2007. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells. J Biol Chem 282: 37341\u20139.", "journal-title": "J Biol Chem"}, {"key": "14_CR10_14", "doi-asserted-by": "crossref", "first-page": "8383", "DOI": "10.1128/MCB.19.12.8383", "volume": "19", "author": "C. L. Bevan", "year": "1999", "unstructured": "Bevan, C. L., S. Hoare, F. Claessens, D. M. Heery, and M. G. Parker. 1999. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 19: 8383\u201392.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR11_14", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1038/nrm1616", "volume": "6", "author": "L. Bordone", "year": "2005", "unstructured": "Bordone, L., and L. Guarente. 2005. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6: 298\u2013305.", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "14_CR12_14", "doi-asserted-by": "crossref", "first-page": "2190", "DOI": "10.1073/pnas.0506281103", "volume": "103", "author": "C. J. Burd", "year": "2006", "unstructured": "Burd, C. J., C. E. Petre, L. M. Morey, Y. Wang, M. P. Revelo, C. A. Haiman, S. Lu, C. M. Fenoglio-Preiser, J. Li, E. S. Knudsen, J. Wong, and K. E. Knudsen. 2006. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. Proc Natl Acad Sci USA 103: 2190\u20135.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR13_14", "doi-asserted-by": "crossref", "first-page": "558", "DOI": "10.1016/0003-9861(72)90174-9", "volume": "148", "author": "P. Byvoet", "year": "1972", "unstructured": "Byvoet, P., G. R. Shepherd, J. M. Hardin, and B. J. Noland. 1972. The distribution and turnover of labeled methyl groups in histone fractions of cultured mammalian cells. Arch Biochem Biophys 148: 558\u201367.", "journal-title": "Arch Biochem Biophys"}, {"key": "14_CR14_14", "doi-asserted-by": "crossref", "first-page": "1438", "DOI": "10.1210/me.2003-0313", "volume": "18", "author": "L. Callewaert", "year": "2004", "unstructured": "Callewaert, L., G. Verrijdt, A. Haelens, and F. Claessens. 2004. Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements. Mol Endocrinol 18: 1438\u201349.", "journal-title": "Mol Endocrinol"}, {"key": "14_CR15_14", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1083/jcb.200211099", "volume": "161", "author": "G. Castoria", "year": "2003", "unstructured": "Castoria, G., M. Lombardi, M. V. Barone, A. Bilancio, M. Di Domenico, D. Bottero, F. Vitale, A. Migliaccio, and F. Auricchio. 2003. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 161: 547\u201356.", "journal-title": "J Cell Biol"}, {"key": "14_CR16_14", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/j.steroids.2004.05.001", "volume": "69", "author": "G. Castoria", "year": "2004", "unstructured": "Castoria, G., M. Lombardi, M. V. Barone, A. Bilancio, M. Di Domenico, A. De Falco, L. Varricchio, D. Bottero, M. Nanayakkara, A. Migliaccio, and F. Auricchio. 2004. Rapid signalling pathway activation by androgens in epithelial and stromal cells. Steroids 69: 517\u201322.", "journal-title": "Steroids"}, {"key": "14_CR17_14", "doi-asserted-by": "crossref", "first-page": "2174", "DOI": "10.1126/science.284.5423.2174", "volume": "284", "author": "D. Chen", "year": "1999", "unstructured": "Chen, D., H. Ma, H. Hong, S. S. Koh, S. M. Huang, B. T. Schurter, D. W. Aswad, and M. R. Stallcup. 1999. Regulation of transcription by a protein methyltransferase. Science 284: 2174\u20137.", "journal-title": "Science"}, {"key": "14_CR18_14", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1038/nm972", "volume": "10", "author": "C. D. Chen", "year": "2004a", "unstructured": "Chen, C. D., D. S. Welsbie, C. Tran, S. H. Baek, R. Chen, R. Vessella, M. G. Rosenfeld, and C. L. Sawyers. 2004a. Molecular determinants of resistance to antiandrogen therapy. Nat Med 10: 33\u20139.", "journal-title": "Nat Med"}, {"key": "14_CR19_14", "doi-asserted-by": "crossref", "first-page": "1345", "DOI": "10.1002/cncr.20518", "volume": "101", "author": "G. Chen", "year": "2004b", "unstructured": "Chen, G., N. Shukeir, A. Potti, K. Sircar, A. Aprikian, D. Goltzman, and S. A. Rabbani. 2004b. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 101: 1345\u201356.", "journal-title": "Cancer"}, {"key": "14_CR20_14", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1128/MCB.26.3.929-939.2006", "volume": "26", "author": "S. Y. Chen", "year": "2006", "unstructured": "Chen, S. Y., G. Wulf, X. Z. Zhou, M. A. Rubin, K. P. Lu, and S. P. Balk. 2006. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction. Mol Cell Biol 26: 929\u201339.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR21_14", "doi-asserted-by": "crossref", "first-page": "6021", "DOI": "10.1128/MCB.24.13.6021-6028.2004", "volume": "24", "author": "J. Cheng", "year": "2004", "unstructured": "Cheng, J., D. Wang, Z. Wang, and E. T. Yeh. 2004. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol 24: 6021\u20138.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR22_14", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1593/neo.06445", "volume": "8", "author": "J. Cheng", "year": "2006", "unstructured": "Cheng, J., T. Bawa, P. Lee, L. Gong, and E. T. Yeh. 2006. Role of desumoylation in the development of prostate cancer. Neoplasia 8: 667\u201376.", "journal-title": "Neoplasia"}, {"key": "14_CR23_14", "doi-asserted-by": "crossref", "first-page": "390", "DOI": "10.1126/science.1099196", "volume": "305", "author": "H. Y. Cohen", "year": "2004", "unstructured": "Cohen, H. Y., C. Miller, K. J. Bitterman, N. R. Wall, B. Hekking, B. Kessler, K. T. Howitz, M. Gorospe, R. de Cabo, and D. A. Sinclair. 2004. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305: 390\u20132.", "journal-title": "Science"}, {"key": "14_CR24_14", "doi-asserted-by": "crossref", "first-page": "970", "DOI": "10.1038/sj.bjc.6603615", "volume": "96", "author": "C. E. Comstock", "year": "2007", "unstructured": "Comstock, C. E., M. P. Revelo, C. R. Buncher, and K. E. Knudsen. 2007. Impact of differential cyclin D1 expression and localisation in prostate cancer. Br J Cancer 96: 970\u20139.", "journal-title": "Br J Cancer"}, {"key": "14_CR25_14", "first-page": "5474", "volume": "54", "author": "Z. Culig", "year": "1994", "unstructured": "Culig, Z., A. Hobisch, M. V. Cronauer, C. Radmayr, J. Trapman, A. Hittmair, G. Bartsch, and H. Klocker. 1994. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54: 5474\u20138.", "journal-title": "Cancer Res"}, {"key": "14_CR26_14", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.4161/cc.4.7.1824", "volume": "4", "author": "J. A. Daniel", "year": "2005", "unstructured": "Daniel, J. A., M. G. Pray-Grant, and P. A. Grant. 2005. Effector proteins for methylated histones: an expanding family. Cell Cycle 4: 919\u201326.", "journal-title": "Cell Cycle"}, {"key": "14_CR27_14", "doi-asserted-by": "crossref", "first-page": "18084", "DOI": "10.1074/jbc.M102285200", "volume": "277", "author": "A. David", "year": "2002", "unstructured": "David, A., N. Mabjeesh, I. Azar, S. Biton, S. Engel, J. Bernstein, J. Romano, Y. Avidor, T. Waks, Z. Eshhar, S. Z. Langer, B. Lifschitz-Mercer, H. Matzkin, G. Rotman, A. Toporik, K. Savitsky, and L. Mintz. 2002. Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins. J Biol Chem 277: 18084\u201390.", "journal-title": "J Biol Chem"}, {"key": "14_CR28_14", "first-page": "5632", "volume": "62", "author": "J. D. Debes", "year": "2002", "unstructured": "Debes, J. D., L. J. Schmidt, H. Huang, and D. J. Tindall. 2002. p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6. Cancer Res 62: 5632\u20136.", "journal-title": "Cancer Res"}, {"key": "14_CR29_14", "doi-asserted-by": "crossref", "first-page": "10449", "DOI": "10.1158/0008-5472.CAN-06-2582", "volume": "66", "author": "S. J. Desai", "year": "2006", "unstructured": "Desai, S. J., A. H. Ma, C. G. Tepper, H. W. Chen, and H. J. Kung. 2006. Inappropriate activation of the androgen receptor by nonsteroids: involvement of the Src kinase pathway and its therapeutic implications. Cancer Res 66: 10449\u201359.", "journal-title": "Cancer Res"}, {"key": "14_CR30_14", "doi-asserted-by": "crossref", "first-page": "4863", "DOI": "10.1128/MCB.02144-06", "volume": "27", "author": "X. Dong", "year": "2007", "unstructured": "Dong, X., J. Sweet, J. R. Challis, T. Brown, and S. J. Lye. 2007. Transcriptional activity of androgen receptor is modulated by two RNA splicing factors, PSF and p54nrb. Mol Cell Biol 27: 4863\u201375.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR31_14", "doi-asserted-by": "crossref", "first-page": "8563", "DOI": "10.1128/MCB.23.23.8563-8575.2003", "volume": "23", "author": "M. Fu", "year": "2003", "unstructured": "Fu, M., M. Rao, C. Wang, T. Sakamaki, J. Wang, D. Di Vizio, X. Zhang, C. Albanese, S. Balk, C. Chang, S. Fan, E. Rosen, J. J. Palvimo, O. A. Janne, S. Muratoglu, M. L. Avantaggiati, and R. G. Pestell. 2003. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 23: 8563\u201375.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR32_14", "doi-asserted-by": "crossref", "first-page": "1199", "DOI": "10.1016/j.bcp.2004.05.037", "volume": "68", "author": "M. Fu", "year": "2004", "unstructured": "Fu, M., C. Wang, X. Zhang, and R. G. Pestell. 2004. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 68: 1199\u2013208.", "journal-title": "Biochem Pharmacol"}, {"key": "14_CR33_14", "doi-asserted-by": "crossref", "first-page": "8122", "DOI": "10.1128/MCB.00289-06", "volume": "26", "author": "M. Fu", "year": "2006", "unstructured": "Fu, M., M. Liu, A. A. Sauve, X. Jiao, X. Zhang, X. Wu, M. J. Powell, T. Yang, W. Gu, M. L. Avantaggiati, N. Pattabiraman, T. G. Pestell, F. Wang, A. A. Quong, C. Wang, and R. G. Pestell. 2006. Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol 26: 8122\u201335.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR34_14", "doi-asserted-by": "crossref", "first-page": "6116", "DOI": "10.1128/MCB.00900-07", "volume": "27", "author": "F. Furuya", "year": "2007", "unstructured": "Furuya, F., C. J. Guigon, L. Zhao, C. Lu, J. A. Hanover, and S. Y. Cheng. 2007. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Mol Cell Biol 27: 6116\u201326.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR35_14", "doi-asserted-by": "crossref", "first-page": "1707", "DOI": "10.1210/en.2004-1198", "volume": "146", "author": "X. Gao", "year": "2005", "unstructured": "Gao, X., S. K. Mohsin, Z. Gatalica, G. Fu, P. Sharma, and Z. Nawaz. 2005. Decreased expression of e6-associated protein in breast and prostate carcinomas. Endocrinology 146: 1707\u201312.", "journal-title": "Endocrinology"}, {"key": "14_CR36_14", "first-page": "279", "volume": "59", "author": "D. Gioeli", "year": "1999", "unstructured": "Gioeli, D., J. W. Mandell, G. R. Petroni, H. F. Frierson, Jr., and M. J. Weber. 1999. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 59: 279\u201384.", "journal-title": "Cancer Res"}, {"key": "14_CR37_14", "doi-asserted-by": "crossref", "first-page": "1043", "DOI": "10.1016/S1097-2765(03)00141-2", "volume": "11", "author": "D. Girdwood", "year": "2003", "unstructured": "Girdwood, D., D. Bumpass, O. A. Vaughan, A. Thain, L. A. Anderson, A. W. Snowden, E. Garcia-Wilson, N. D. Perkins, and R. T. Hay. 2003. P300 transcriptional repression is mediated by SUMO modification. Mol Cell 11: 1043\u201354.", "journal-title": "Mol Cell"}, {"key": "14_CR38_14", "doi-asserted-by": "crossref", "first-page": "864", "DOI": "10.1073/pnas.74.3.864", "volume": "74", "author": "I. L. Goldknopf", "year": "1977", "unstructured": "Goldknopf, I. L., and H. Busch. 1977. Isopeptide linkage between nonhistone and histone 2A polypeptides of chromosomal conjugate-protein A24. Proc Natl Acad Sci USA 74: 864\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR39_14", "doi-asserted-by": "crossref", "first-page": "2011", "DOI": "10.1038/sj.onc.1209231", "volume": "25", "author": "J. Gong", "year": "2006", "unstructured": "Gong, J., J. Zhu, O. B. Goodman, Jr., R. G. Pestell, P. N. Schlegel, D. M. Nanus, and R. Shen. 2006. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene 25: 2011\u201321.", "journal-title": "Oncogene"}, {"key": "14_CR40_14", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/j.jmb.2004.02.006", "volume": "338", "author": "I. V. Gregoretti", "year": "2004", "unstructured": "Gregoretti, I. V., Y. M. Lee, and H. V. Goodson. 2004. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 338: 17\u201331.", "journal-title": "J Mol Biol"}, {"key": "14_CR41_14", "first-page": "4315", "volume": "61", "author": "C. W. Gregory", "year": "2001", "unstructured": "Gregory, C. W., B. He, R. T. Johnson, O. H. Ford, J. L. Mohler, F. S. French, and E. M. Wilson. 2001. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61: 4315\u20139.", "journal-title": "Cancer Res"}, {"key": "14_CR42_14", "doi-asserted-by": "crossref", "first-page": "7119", "DOI": "10.1074/jbc.M307649200", "volume": "279", "author": "C. W. Gregory", "year": "2004", "unstructured": "Gregory, C. W., X. Fei, L. A. Ponguta, B. He, H. M. Bill, F. S. French, and E. M. Wilson. 2004. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J Biol Chem 279: 7119\u201330.", "journal-title": "J Biol Chem"}, {"key": "14_CR43_14", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/j.ccr.2006.08.021", "volume": "10", "author": "Z. Guo", "year": "2006", "unstructured": "Guo, Z., B. Dai, T. Jiang, K. Xu, Y. Xie, O. Kim, I. Nesheiwat, X. Kong, J. Melamed, V. D. Handratta, V. C. Njar, A. M. Brodie, L. R. Yu, T. D. Veenstra, H. Chen, and Y. Qiu. 2006. Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell 10: 309\u201319.", "journal-title": "Cancer Cell"}, {"key": "14_CR44_14", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1016/j.molcel.2007.07.003", "volume": "27", "author": "A. L. Haas", "year": "2007", "unstructured": "Haas, A. L. 2007. Structural insights into early events in the conjugation of ubiquitin and ubiquitin-like proteins. Mol Cell 27: 174\u20135.", "journal-title": "Mol Cell"}, {"key": "14_CR45_14", "doi-asserted-by": "crossref", "first-page": "2466", "DOI": "10.1038/sj.onc.1206342", "volume": "22", "author": "K. Halkidou", "year": "2003", "unstructured": "Halkidou, K., V. J. Gnanapragasam, P. B. Mehta, I. R. Logan, M. E. Brady, S. Cook, H. Y. Leung, D. E. Neal, and C. N. Robson. 2003. Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene 22: 2466\u201377.", "journal-title": "Oncogene"}, {"key": "14_CR46_14", "first-page": "160", "volume": "48", "author": "M. L. He", "year": "2005", "unstructured": "He, M. L., A. L. Jiang, P. J. Zhang, X. Y. Hu, Z. F. Liu, H. Q. Yuan, and J. Y. Zhang. 2005. Identification of androgen-responsive element ARE and Sp1 element in the maspin promoter. Chin J Physiol 48: 160\u20136.", "journal-title": "Chin J Physiol"}, {"key": "14_CR47_14", "doi-asserted-by": "crossref", "first-page": "3422", "DOI": "10.1158/0008-5472.CAN-06-2836", "volume": "67", "author": "H. V. Heemers", "year": "2007", "unstructured": "Heemers, H. V., T. J. Sebo, J. D. Debes, K. M. Regan, K. A. Raclaw, L. M. Murphy, A. Hobisch, Z. Culig, and D. J. Tindall. 2007. Androgen deprivation increases p300 expression in prostate cancer cells. Cancer Res 67: 3422\u201330.", "journal-title": "Cancer Res"}, {"key": "14_CR48_14", "doi-asserted-by": "crossref", "first-page": "6612", "DOI": "10.1158/0008-5472.CAN-07-0085", "volume": "67", "author": "D. M. Huffman", "year": "2007", "unstructured": "Huffman, D. M., W. E. Grizzle, M. M. Bamman, J. S. Kim, I. A. Eltoum, A. Elgavish, and T. R. Nagy. 2007. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res 67: 6612\u20138.", "journal-title": "Cancer Res"}, {"key": "14_CR49_14", "doi-asserted-by": "crossref", "first-page": "11341", "DOI": "10.1158/0008-5472.CAN-06-1570", "volume": "66", "author": "P. Kahl", "year": "2006", "unstructured": "Kahl, P., L. Gullotti, L. C. Heukamp, S. Wolf, N. Friedrichs, R. Vorreuther, G. Solleder, P. J. Bastian, J. Ellinger, E. Metzger, R. Schule, and R. Buettner. 2006. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 66: 11341\u20137.", "journal-title": "Cancer Res"}, {"key": "14_CR50_14", "doi-asserted-by": "crossref", "first-page": "1145", "DOI": "10.1016/j.bcp.2004.03.045", "volume": "68", "author": "E. Kalkhoven", "year": "2004", "unstructured": "Kalkhoven, E. 2004. CBP and p300: HATs for different occasions. Biochem Pharmacol 68: 1145\u201355.", "journal-title": "Biochem Pharmacol"}, {"key": "14_CR51_14", "doi-asserted-by": "crossref", "first-page": "48366", "DOI": "10.1074/jbc.M209074200", "volume": "277", "author": "Z. Kang", "year": "2002", "unstructured": "Kang, Z., A. Pirskanen, O. A. Janne, and J. J. Palvimo. 2002. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 277: 48366\u201371.", "journal-title": "J Biol Chem"}, {"key": "14_CR52_14", "doi-asserted-by": "crossref", "first-page": "3165", "DOI": "10.1016/j.yexcr.2006.06.018", "volume": "312", "author": "U. Karvonen", "year": "2006", "unstructured": "Karvonen, U., O. A. Janne, and J. J. Palvimo. 2006. Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. Exp Cell Res 312: 3165\u201383.", "journal-title": "Exp Cell Res"}, {"key": "14_CR53_14", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1210/me.2005-0110", "volume": "20", "author": "O. Y. Khan", "year": "2006", "unstructured": "Khan, O. Y., G. Fu, A. Ismail, S. Srinivasan, X. Cao, Y. Tu, S. Lu, and Z. Nawaz. 2006. Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol Endocrinol 20: 544\u201359.", "journal-title": "Mol Endocrinol"}, {"key": "14_CR54_14", "doi-asserted-by": "crossref", "first-page": "1986", "DOI": "10.1210/mend.14.12.0569", "volume": "14", "author": "N. Kotaja", "year": "2000", "unstructured": "Kotaja, N., S. Aittomaki, O. Silvennoinen, J. J. Palvimo, and O. A. Janne. 2000. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol Endocrinol 14: 1986\u20132000.", "journal-title": "Mol Endocrinol"}, {"key": "14_CR55_14", "doi-asserted-by": "crossref", "first-page": "30283", "DOI": "10.1074/jbc.M204768200", "volume": "277", "author": "N. Kotaja", "year": "2002", "unstructured": "Kotaja, N., U. Karvonen, O. A. Janne, and J. J. Palvimo. 2002. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem 277: 30283\u20138.", "journal-title": "J Biol Chem"}, {"key": "14_CR56_14", "doi-asserted-by": "crossref", "first-page": "4910", "DOI": "10.1128/MCB.20.13.4910-4921.2000", "volume": "20", "author": "E. Lalli", "year": "2000", "unstructured": "Lalli, E., K. Ohe, C. Hindelang, and P. Sassone-Corsi. 2000. Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol Cell Biol 20: 4910\u201321.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR57_14", "doi-asserted-by": "crossref", "first-page": "8476", "DOI": "10.1074/jbc.M511093200", "volume": "281", "author": "D. Y. Lee", "year": "2006", "unstructured": "Lee, D. Y., J. P. Northrop, M. H. Kuo, and M. R. Stallcup. 2006. Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors. J Biol Chem 281: 8476\u201385.", "journal-title": "J Biol Chem"}, {"key": "14_CR58_14", "doi-asserted-by": "crossref", "first-page": "928", "DOI": "10.1097/00000478-200407000-00013", "volume": "28", "author": "R. Li", "year": "2004", "unstructured": "Li, R., T. Wheeler, H. Dai, A. Frolov, T. Thompson, and G. Ayala. 2004. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol 28: 928\u201334.", "journal-title": "Am J Surg Pathol"}, {"key": "14_CR59_14", "doi-asserted-by": "crossref", "first-page": "36570", "DOI": "10.1074/jbc.M204751200", "volume": "277", "author": "H. K. Lin", "year": "2002", "unstructured": "Lin, H. K., S. Altuwaijri, W. J. Lin, P. Y. Kan, L. L. Collins, and C. Chang. 2002. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 277: 36570\u20136.", "journal-title": "J Biol Chem"}, {"key": "14_CR60_14", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1210/mend.14.5.0461", "volume": "14", "author": "S. Lu", "year": "2000", "unstructured": "Lu, S., G. Jenster, and D. E. Epner. 2000. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. Mol Endocrinol 14: 753\u201360.", "journal-title": "Mol Endocrinol"}, {"key": "14_CR61_14", "doi-asserted-by": "crossref", "first-page": "8056", "DOI": "10.1128/MCB.21.23.8056-8067.2001", "volume": "21", "author": "Z. Q. Ma", "year": "2001", "unstructured": "Ma, Z. Q., Z. Liu, E. S. Ngan, and S. Y. Tsai. 2001. Cdc25B functions as a novel coactivator for the steroid receptors. Mol Cell Biol 21: 8056\u201367.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR62_14", "doi-asserted-by": "crossref", "first-page": "8439", "DOI": "10.1158/0008-5472.CAN-06-1636", "volume": "66", "author": "A. H. Ma", "year": "2006", "unstructured": "Ma, A. H., L. Xia, S. J. Desai, D. L. Boucher, Y. Guan, H. M. Shih, X. B. Shi, R. W. deVere White, H. W. Chen, C. G. Tepper, and H. J. Kung. 2006. Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells. Cancer Res 66: 8439\u201347.", "journal-title": "Cancer Res"}, {"key": "14_CR63_14", "doi-asserted-by": "crossref", "first-page": "8438", "DOI": "10.1073/pnas.0700420104", "volume": "104", "author": "N. P. Mahajan", "year": "2007", "unstructured": "Mahajan, N. P., Y. Liu, S. Majumder, M. R. Warren, C. E. Parker, J. L. Mohler, H. S. Earp, and Y. E. Whang. 2007. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci USA 104: 8438\u201343.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR64_14", "doi-asserted-by": "crossref", "first-page": "1292", "DOI": "10.1002/pros.20438", "volume": "66", "author": "S. Majumder", "year": "2006", "unstructured": "Majumder, S., Y. Liu, O. H. Ford, III, J. L. Mohler, and Y. E. Whang. 2006. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate 66: 1292\u2013301.", "journal-title": "Prostate"}, {"key": "14_CR65_14", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1093/emboj/cdg023", "volume": "22", "author": "E. Metzger", "year": "2003", "unstructured": "Metzger, E., J. M. Muller, S. Ferrari, R. Buettner, and R. Schule. 2003. A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer. EMBO J 22: 270\u201380.", "journal-title": "EMBO J"}, {"key": "14_CR66_14", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1038/nature04020", "volume": "437", "author": "E. Metzger", "year": "2005", "unstructured": "Metzger, E., M. Wissmann, N. Yin, J. M. Muller, R. Schneider, A. H. Peters, T. Gunther, R. Buettner, and R. Schule. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437: 436\u20139.", "journal-title": "Nature"}, {"key": "14_CR67_14", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1038/ncb1668", "volume": "10", "author": "E. Metzger", "year": "2008", "unstructured": "Metzger, E., N. Yin, M. Wissmann, N. Kunowska, K. Fischer, N. Friedrichs, D. Patnaik, J. M. Higgins, N. Potier, K. H. Scheidtmann, R. Buettner, and R. Schule. 2008. Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat Cell Biol 10: 53\u201360.", "journal-title": "Nat Cell Biol"}, {"key": "14_CR68_14", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1042/BJ20070140", "volume": "404", "author": "S. Michan", "year": "2007", "unstructured": "Michan, S., and D. Sinclair. 2007. Sirtuins in mammals: insights into their biological function. Biochem J 404: 1\u201313.", "journal-title": "Biochem J"}, {"key": "14_CR69_14", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1210/me.2006-0269", "volume": "21", "author": "S. S. Nair", "year": "2007", "unstructured": "Nair, S. S., Z. Guo, J. M. Mueller, S. Koochekpour, Y. Qiu, R. R. Tekmal, R. Schule, H. J. Kung, R. Kumar, and R. K. Vadlamudi. 2007. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2. Mol Endocrinol 21: 613\u201324.", "journal-title": "Mol Endocrinol"}, {"key": "14_CR70_14", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1038/sj.onc.1206121", "volume": "22", "author": "E. S. Ngan", "year": "2003", "unstructured": "Ngan, E. S., Y. Hashimoto, Z. Q. Ma, M. J. Tsai, and S. Y. Tsai. 2003. Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. Oncogene 22: 734\u20139.", "journal-title": "Oncogene"}, {"key": "14_CR71_14", "doi-asserted-by": "crossref", "first-page": "3111", "DOI": "10.1038/sj.onc.1210981", "volume": "27", "author": "N. A. Olshavsky", "year": "2008", "unstructured": "Olshavsky, N. A., E. M. Groh, C. E. Comstock, L. M. Morey, Y. Wang, M. P. Revelo, C. Burd, J. Meller, and K. E. Knudsen. 2008. Cyclin D3 action in androgen receptor regulation and prostate cancer. Oncogene 27: 3111\u201321.", "journal-title": "Oncogene"}, {"key": "14_CR72_14", "doi-asserted-by": "crossref", "first-page": "1354", "DOI": "10.1126/science.270.5240.1354", "volume": "270", "author": "S. A. Onate", "year": "1995", "unstructured": "Onate, S. A., S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354\u20137.", "journal-title": "Science"}, {"key": "14_CR73_14", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/j.steroids.2006.12.001", "volume": "72", "author": "V. M. Popov", "year": "2007", "unstructured": "Popov, V. M., C. Wang, L. A. Shirley, A. Rosenberg, S. Li, M. Nevalainen, M. Fu, and R. G. Pestell. 2007. The functional significance of nuclear receptor acetylation. Steroids 72: 221\u201330.", "journal-title": "Steroids"}, {"key": "14_CR74_14", "doi-asserted-by": "crossref", "first-page": "19441", "DOI": "10.1074/jbc.274.27.19441", "volume": "274", "author": "H. Poukka", "year": "1999", "unstructured": "Poukka, H., P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne. 1999. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J Biol Chem 274: 19441\u20136.", "journal-title": "J Biol Chem"}, {"key": "14_CR75_14", "doi-asserted-by": "crossref", "first-page": "14145", "DOI": "10.1073/pnas.97.26.14145", "volume": "97", "author": "H. Poukka", "year": "2000", "unstructured": "Poukka, H., U. Karvonen, O. A. Janne, and J. J. Palvimo. 2000. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 97: 14145\u201350.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR76_14", "doi-asserted-by": "crossref", "first-page": "4475", "DOI": "10.1074/jbc.275.6.4475", "volume": "275", "author": "B. G. Rowan", "year": "2000", "unstructured": "Rowan, B. G., N. L. Weigel, and B. W. O'Malley. 2000. Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275: 4475\u201383.", "journal-title": "J Biol Chem"}, {"key": "14_CR77_14", "first-page": "8029", "volume": "63", "author": "G. Sathya", "year": "2003", "unstructured": "Sathya, G., C. Y. Chang, D. Kazmin, C. E. Cook, and D. P. McDonnell. 2003. Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion. Cancer Res 63: 8029\u201336.", "journal-title": "Cancer Res"}, {"key": "14_CR78_14", "doi-asserted-by": "crossref", "first-page": "7220", "DOI": "10.1128/MCB.00274-07", "volume": "27", "author": "A. G. Scibetta", "year": "2007", "unstructured": "Scibetta, A. G., S. Santangelo, J. Coleman, D. Hall, T. Chaplin, J. Copier, S. Catchpole, J. Burchell, and J. Taylor-Papadimitriou. 2007. Functional analysis of the transcription repressor PLU-1/JARID1B. Mol Cell Biol 27: 7220\u201335.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR79_14", "doi-asserted-by": "crossref", "first-page": "1262", "DOI": "10.1038/nature03672", "volume": "435", "author": "D. B. Seligson", "year": "2005", "unstructured": "Seligson, D. B., S. Horvath, T. Shi, H. Yu, S. Tze, M. Grunstein, and S. K. Kurdistani. 2005. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435: 1262\u20136.", "journal-title": "Nature"}, {"key": "14_CR80_14", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1016/S1097-2765(02)00471-9", "volume": "9", "author": "Y. Shang", "year": "2002", "unstructured": "Shang, Y., M. Myers, and M. Brown. 2002. Formation of the androgen receptor transcription complex. Mol Cell 9: 601\u201310.", "journal-title": "Mol Cell"}, {"key": "14_CR81_14", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1002/dvdy.10397", "volume": "228", "author": "M. M. Shen", "year": "2003", "unstructured": "Shen, M. M., and C. Abate-Shen. 2003. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 228: 767\u201378.", "journal-title": "Dev Dyn"}, {"key": "14_CR82_14", "first-page": "149", "volume": "286", "author": "S. Sigismund", "year": "2004", "unstructured": "Sigismund, S., S. Polo, and P. P. Di Fiore. 2004. Signaling through monoubiquitination. Curr Top Microbiol Immunol 286: 149\u201385.", "journal-title": "Curr Top Microbiol Immunol"}, {"key": "14_CR83_14", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1038/38304", "volume": "389", "author": "T. E. Spencer", "year": "1997", "unstructured": "Spencer, T. E., G. Jenster, M. M. Burcin, C. D. Allis, J. Zhou, C. A. Mizzen, N. J. McKenna, S. A. Onate, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389: 194\u20138.", "journal-title": "Nature"}, {"key": "14_CR84_14", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/j.jsbmb.2007.05.031", "volume": "107", "author": "J. Sun", "year": "2007", "unstructured": "Sun, J., A. L. Blair, S. E. Aiyar, and R. Li. 2007. Cofactor of BRCA1 modulates androgen-dependent transcription and alternative splicing. J Steroid Biochem Mol Biol 107: 131\u20139.", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "14_CR85_14", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1016/j.molcel.2006.11.026", "volume": "24", "author": "S. M. Sykes", "year": "2006", "unstructured": "Sykes, S. M., H. S. Mellert, M. A. Holbert, K. Li, R. Marmorstein, W. S. Lane, and S. B. McMahon. 2006. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24: 841\u201351.", "journal-title": "Mol Cell"}, {"key": "14_CR86_14", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.1126/science.1117679", "volume": "310", "author": "S. A. Tomlins", "year": "2005", "unstructured": "Tomlins, S. A., D. R. Rhodes, S. Perner, S. M. Dhanasekaran, R. Mehra, X. W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, C. Lee, J. E. Montie, R. B. Shah, K. J. Pienta, M. A. Rubin, and A. M. Chinnaiyan. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644\u20138.", "journal-title": "Science"}, {"key": "14_CR87_14", "first-page": "4709", "volume": "60", "author": "C. I. Truica", "year": "2000", "unstructured": "Truica, C. I., S. Byers, and E. P. Gelmann. 2000. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60: 4709\u201313.", "journal-title": "Cancer Res"}, {"key": "14_CR88_14", "doi-asserted-by": "crossref", "first-page": "38087", "DOI": "10.1074/jbc.M203313200", "volume": "277", "author": "T. Ueda", "year": "2002", "unstructured": "Ueda, T., N. R. Mawji, N. Bruchovsky, and M. D. Sadar. 2002. Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J Biol Chem 277: 38087\u201394.", "journal-title": "J Biol Chem"}, {"key": "14_CR89_14", "doi-asserted-by": "crossref", "first-page": "7156", "DOI": "10.1158/0008-5472.CAN-04-1121", "volume": "64", "author": "E. Unni", "year": "2004", "unstructured": "Unni, E., S. Sun, B. Nan, M. J. McPhaul, B. Cheskis, M. A. Mancini, and M. Marcelli. 2004. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 64: 7156\u201368.", "journal-title": "Cancer Res"}, {"key": "14_CR90_14", "doi-asserted-by": "crossref", "first-page": "15901", "DOI": "10.1073/pnas.0508014102", "volume": "102", "author": "E. H. van der Horst", "year": "2005", "unstructured": "van der Horst, E. H., Y. Y. Degenhardt, A. Strelow, A. Slavin, L. Chinn, J. Orf, M. Rong, S. Li, L. H. See, K. Q. Nguyen, T. Hoey, H. Wesche, and S. Powers. 2005. Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci USA 102: 15901\u20136.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR91_14", "first-page": "273", "volume": "48", "author": "D. Waltregny", "year": "2004", "unstructured": "Waltregny, D., B. North, F. Van Mellaert, J. de Leval, E. Verdin, and V. Castronovo. 2004. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells. Eur J Histochem 48: 273\u201390.", "journal-title": "Eur J Histochem"}, {"key": "14_CR92_14", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1126/science.1060781", "volume": "293", "author": "H. Wang", "year": "2001", "unstructured": "Wang, H., Z. Q. Huang, L. Xia, Q. Feng, H. Erdjument-Bromage, B. D. Strahl, S. D. Briggs, C. D. Allis, J. Wong, P. Tempst, and Y. Zhang. 2001. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293: 853\u20137.", "journal-title": "Science"}, {"key": "14_CR93_14", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1016/j.molcel.2005.07.018", "volume": "19", "author": "Q. Wang", "year": "2005", "unstructured": "Wang, Q., J. S. Carroll, and M. Brown. 2005. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19: 631\u201342.", "journal-title": "Mol Cell"}, {"key": "14_CR94_14", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1038/ncb1546", "volume": "9", "author": "M. Wissmann", "year": "2007", "unstructured": "Wissmann, M., N. Yin, J. M. Muller, H. Greschik, B. D. Fodor, T. Jenuwein, C. Vogler, R. Schneider, T. Gunther, R. Buettner, E. Metzger, and R. Schule. 2007. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 9: 347\u201353.", "journal-title": "Nat Cell Biol"}, {"key": "14_CR95_14", "doi-asserted-by": "crossref", "first-page": "937", "DOI": "10.1016/j.molcel.2004.08.019", "volume": "15", "author": "R. C. Wu", "year": "2004", "unstructured": "Wu, R. C., J. Qin, P. Yi, J. Wong, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 2004. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell 15: 937\u201349.", "journal-title": "Mol Cell"}, {"key": "14_CR96_14", "doi-asserted-by": "crossref", "first-page": "19226", "DOI": "10.1073/pnas.0700735104", "volume": "104", "author": "Y. Xiang", "year": "2007", "unstructured": "Xiang, Y., Z. Zhu, G. Han, X. Ye, B. Xu, Z. Peng, Y. Ma, Y. Yu, H. Lin, A. P. Chen, and C. D. Chen. 2007. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci USA 104: 19226\u201331.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR97_14", "doi-asserted-by": "crossref", "first-page": "7789", "DOI": "10.1073/pnas.0602567103", "volume": "103", "author": "L. Xin", "year": "2006", "unstructured": "Xin, L., M. A. Teitell, D. A. Lawson, A. Kwon, I. K. Mellinghoff, and O. N. Witte. 2006. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc Natl Acad Sci USA 103: 7789\u201394.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR98_14", "doi-asserted-by": "crossref", "first-page": "1922", "DOI": "10.1126/science.279.5358.1922", "volume": "279", "author": "J. Xu", "year": "1998", "unstructured": "Xu, J., Y. Qiu, F. J. DeMayo, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1998. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279: 1922\u20135.", "journal-title": "Science"}, {"key": "14_CR99_14", "doi-asserted-by": "crossref", "first-page": "6379", "DOI": "10.1073/pnas.120166297", "volume": "97", "author": "J. Xu", "year": "2000", "unstructured": "Xu, J., L. Liao, G. Ning, H. Yoshida-Komiya, C. Deng, and B. W. O'Malley. 2000. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 97: 6379\u201384.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR100_14", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1023/A:1020016208071", "volume": "3", "author": "J. Xu", "year": "2002", "unstructured": "Xu, J., and B. W. O'Malley. 2002. Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function. Rev Endocr Metab Disord 3: 185\u201392.", "journal-title": "Rev Endocr Metab Disord"}, {"key": "14_CR101_14", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1016/j.cell.2006.03.027", "volume": "125", "author": "K. Yamane", "year": "2006", "unstructured": "Yamane, K., C. Toumazou, Y. Tsukada, H. Erdjument-Bromage, P. Tempst, J. Wong, and Y. Zhang. 2006. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125: 483\u201395.", "journal-title": "Cell"}, {"key": "14_CR102_14", "doi-asserted-by": "crossref", "first-page": "11039", "DOI": "10.1158/0008-5472.CAN-06-2442", "volume": "66", "author": "J. Yan", "year": "2006", "unstructured": "Yan, J., C. T. Yu, M. Ozen, M. Ittmann, S. Y. Tsai, and M. J. Tsai. 2006. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res 66: 11039\u201346.", "journal-title": "Cancer Res"}, {"key": "14_CR103_14", "doi-asserted-by": "crossref", "first-page": "9316", "DOI": "10.1158/0008-5472.CAN-06-1902", "volume": "66", "author": "J. Yu", "year": "2006", "unstructured": "Yu, J., C. Palmer, T. Alenghat, Y. Li, G. Kao, and M. A. Lazar. 2006. The corepressor silencing mediator for retinoid and thyroid hormone receptor facilitates cellular recovery from DNA double-strand breaks. Cancer Res 66: 9316\u201322.", "journal-title": "Cancer Res"}, {"key": "14_CR104_14", "doi-asserted-by": "crossref", "first-page": "30031", "DOI": "10.1074/jbc.M203811200", "volume": "277", "author": "Y. Zhao", "year": "2002", "unstructured": "Zhao, Y., K. Goto, M. Saitoh, T. Yanase, M. Nomura, T. Okabe, R. Takayanagi, and H. Nawata. 2002. Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor. J Biol Chem 277: 30031\u20139.", "journal-title": "J Biol Chem"}, {"key": "14_CR105_14", "doi-asserted-by": "crossref", "first-page": "4002", "DOI": "10.1074/jbc.M509260200", "volume": "281", "author": "Z. Zheng", "year": "2006", "unstructured": "Zheng, Z., C. Cai, J. Omwancha, S. Y. Chen, T. Baslan, and L. Shemshedini. 2006. SUMO-3 enhances androgen receptor transcriptional activity through a sumoylation-independent mechanism in prostate cancer cells. J Biol Chem 281: 4002\u201312.", "journal-title": "J Biol Chem"}, {"key": "14_CR106_14", "doi-asserted-by": "crossref", "first-page": "7742", "DOI": "10.1128/MCB.23.21.7742-7755.2003", "volume": "23", "author": "G. Zhou", "year": "2003", "unstructured": "Zhou, G., Y. Hashimoto, I. Kwak, S. Y. Tsai, and M. J. Tsai. 2003. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol 23: 7742\u201355.", "journal-title": "Mol Cell Biol"}, {"key": "14_CR107_14", "doi-asserted-by": "crossref", "first-page": "7976", "DOI": "10.1158/0008-5472.CAN-04-4076", "volume": "65", "author": "H. J. Zhou", "year": "2005", "unstructured": "Zhou, H. J., J. Yan, W. Luo, G. Ayala, S. H. Lin, H. Erdem, M. Ittmann, S. Y. Tsai, and M. J. Tsai. 2005. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 65: 7976\u201383.", "journal-title": "Cancer Res"}, {"key": "14_CR108_14", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1016/j.molcel.2007.07.024", "volume": "27", "author": "P. Zhu", "year": "2007", "unstructured": "Zhu, P., W. Zhou, J. Wang, J. Puc, K. A. Ohgi, H. Erdjument-Bromage, P. Tempst, C. K. Glass, and M. G. Rosenfeld. 2007. A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. Mol Cell 27: 609\u201321.", "journal-title": "Mol Cell"}, {"key": "14_CR109_14", "doi-asserted-by": "crossref", "first-page": "7125", "DOI": "10.1128/MCB.01753-06", "volume": "27", "author": "H. Zong", "year": "2007", "unstructured": "Zong, H., Y. Chi, Y. Wang, Y. Yang, L. Zhang, H. Chen, J. Jiang, Z. Li, Y. Hong, H. Wang, X. Yun, and J. Gu. 2007. Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. Mol Cell Biol 27: 7125\u201342.", "journal-title": "Mol Cell Biol"}], "container-title": ["Androgen Action in Prostate Cancer"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-0-387-69179-4_14", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 26]], "date-time": "2019-04-26T07:10:56Z", "timestamp": 1556262656000}, "score": 35.425274, "issued": {"date-parts": [[2009]]}, "ISBN": ["9780387691770", "9780387691794"], "references-count": 109, "URL": "http://dx.doi.org/10.1007/978-0-387-69179-4_14", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:47:27Z", "timestamp": 1574419647165}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4S", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 4, 1]], "date-time": "2010-04-01T00:00:00Z", "timestamp": 1270080000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2010, 4]]}, "DOI": "10.1016/j.juro.2010.02.872", "type": "journal-article", "created": {"date-parts": [[2010, 3, 23]], "date-time": "2010-03-23T10:16:01Z", "timestamp": 1269339361000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["1288 EVIDENCE FOR A CENTRAL ROLE FOR PELP-1 IN ANDROGEN RECEPTOR MEDIATED GENOMIC SIGNALING IN PROSTATE CANCER"], "prefix": "10.1097", "volume": "183", "author": [{"given": "Lin", "family": "Yang", "sequence": "first", "affiliation": [{"name": "Dallas, TX"}]}, {"given": "Preethi", "family": "Ravindranathan", "sequence": "additional", "affiliation": [{"name": "Dallas, TX"}]}, {"given": "J.T.", "family": "Hsieh", "sequence": "additional", "affiliation": [{"name": "Dallas, TX"}]}, {"given": "Ganesh", "family": "Raj", "sequence": "additional", "affiliation": [{"name": "Dallas, TX"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022534710011286?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022534710011286?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T17:25:14Z", "timestamp": 1560792314000}, "score": 34.949368, "issued": {"date-parts": [[2010, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 4]]}, "issue": "4S"}, "alternative-id": ["10.1016/j.juro.2010.02.872"], "URL": "http://dx.doi.org/10.1016/j.juro.2010.02.872", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T23:28:08Z", "timestamp": 1574810888338}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006, 2, 1]]}, "DOI": "10.21236/ada459172", "type": "report", "created": {"date-parts": [[2017, 7, 14]], "date-time": "2017-07-14T16:13:32Z", "timestamp": 1500048812000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Caveolin-1 Modulates Androgen Receptor Signaling in Advanced Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Michael L.", "family": "Lu", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 14]], "date-time": "2017-07-14T16:13:32Z", "timestamp": 1500048812000}, "score": 34.11199, "subtitle": [""], "issued": {"date-parts": [[2006, 2, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada459172"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T02:47:43Z", "timestamp": 1574822863007}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2004, 2, 1]]}, "DOI": "10.21236/ada427983", "type": "report", "created": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T12:53:55Z", "timestamp": 1502715235000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Caveolin-1 Modulates Androgen Receptor Signaling in Advanced Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Michael L.", "family": "Lu", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T12:53:56Z", "timestamp": 1502715236000}, "score": 34.11199, "subtitle": [""], "issued": {"date-parts": [[2004, 2, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada427983"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T02:33:43Z", "timestamp": 1574822023076}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2005, 2, 1]]}, "DOI": "10.21236/ada434550", "type": "report", "created": {"date-parts": [[2017, 8, 11]], "date-time": "2017-08-11T19:09:09Z", "timestamp": 1502478549000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Caveolin-1 Modulates Androgen Receptor Signaling in Advanced Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Michael L.", "family": "Lu", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 11]], "date-time": "2017-08-11T19:09:10Z", "timestamp": 1502478550000}, "score": 34.11199, "subtitle": [""], "issued": {"date-parts": [[2005, 2, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada434550"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T03:09:15Z", "timestamp": 1574824155191}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 2, 1]]}, "DOI": "10.21236/ada414469", "type": "report", "created": {"date-parts": [[2017, 8, 17]], "date-time": "2017-08-17T15:13:01Z", "timestamp": 1502982781000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Caveolin-1 Modulates Androgen Receptor Signaling in Advanced Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Michael L.", "family": "Lu", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 17]], "date-time": "2017-08-17T15:13:01Z", "timestamp": 1502982781000}, "score": 34.11199, "subtitle": [""], "issued": {"date-parts": [[2003, 2, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada414469"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:34:20Z", "timestamp": 1574418860356}, "reference-count": 0, "publisher": "WORLD SCIENTIFIC", "isbn-type": [{"value": "9789812560674", "type": "print"}, {"value": "9789812569202", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2005, 3]]}, "DOI": "10.1142/9789812569202_0016", "type": "book-chapter", "created": {"date-parts": [[2010, 3, 19]], "date-time": "2010-03-19T03:06:10Z", "timestamp": 1268967970000}, "page": "383-392", "source": "Crossref", "is-referenced-by-count": 0, "title": ["STUDY OF ANDROGEN\u2013ANDROGEN RECEPTOR ROLES IN PROSTATE CANCER USING MICE LACKING FUNCTIONAL PROSTATE ANDROGEN RECEPTOR"], "prefix": "10.1142", "author": [{"given": "Chun-Te", "family": "Wu", "sequence": "first", "affiliation": [{"name": "George H. Whipple Lab for Cancer Research, Departments of Urology, Pathology and Radiation Oncology, and the Cancer Center, University of Rochester, Rochester, New York 14642, USA"}]}, {"given": "Shuyuan", "family": "Yeh", "sequence": "additional", "affiliation": [{"name": "George H. Whipple Lab for Cancer Research, Departments of Urology, Pathology and Radiation Oncology, and the Cancer Center, University of Rochester, Rochester, New York 14642, USA"}]}, {"given": "Qingquan", "family": "Xu", "sequence": "additional", "affiliation": [{"name": "George H. Whipple Lab for Cancer Research, Departments of Urology, Pathology and Radiation Oncology, and the Cancer Center, University of Rochester, Rochester, New York 14642, USA"}]}, {"given": "Zhiming", "family": "Yang", "sequence": "additional", "affiliation": [{"name": "George H. Whipple Lab for Cancer Research, Departments of Urology, Pathology and Radiation Oncology, and the Cancer Center, University of Rochester, Rochester, New York 14642, USA"}]}, {"given": "Philip", "family": "Chang", "sequence": "additional", "affiliation": [{"name": "George H. Whipple Lab for Cancer Research, Departments of Urology, Pathology and Radiation Oncology, and the Cancer Center, University of Rochester, Rochester, New York 14642, USA"}]}, {"given": "Yueh-Chiang", "family": "Hu", "sequence": "additional", "affiliation": [{"name": "George H. Whipple Lab for Cancer Research, Departments of Urology, Pathology and Radiation Oncology, and the Cancer Center, University of Rochester, Rochester, New York 14642, USA"}]}, {"given": "Chawnshang", "family": "Chang", "sequence": "additional", "affiliation": [{"name": "George H. Whipple Lab for Cancer Research, Departments of Urology, Pathology and Radiation Oncology, and the Cancer Center, University of Rochester, Rochester, New York 14642, USA"}]}], "member": "219", "published-online": {"date-parts": [[2012, 1, 26]]}, "container-title": ["Prostate Cancer"], "deposited": {"date-parts": [[2017, 7, 19]], "date-time": "2017-07-19T15:51:15Z", "timestamp": 1500479475000}, "score": 32.405376, "issued": {"date-parts": [[2005, 3]]}, "ISBN": ["9789812560674", "9789812569202"], "references-count": 0, "alternative-id": ["10.1142/9789812569202_0016", "10.1142/5678"], "URL": "http://dx.doi.org/10.1142/9789812569202_0016"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T08:46:53Z", "timestamp": 1574326013476}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "20", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2007, 10, 15]]}, "DOI": "10.1158/0008-5472.can-07-1267", "type": "journal-article", "created": {"date-parts": [[2007, 10, 17]], "date-time": "2007-10-17T21:39:01Z", "timestamp": 1192657141000}, "page": "10067-10077", "source": "Crossref", "is-referenced-by-count": 48, "title": ["Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion Independent Prostate Cancer Cells"], "prefix": "10.1158", "volume": "67", "author": [{"given": "S. M.", "family": "Dehm", "sequence": "first", "affiliation": []}, {"given": "K. M.", "family": "Regan", "sequence": "additional", "affiliation": []}, {"given": "L. J.", "family": "Schmidt", "sequence": "additional", "affiliation": []}, {"given": "D. J.", "family": "Tindall", "sequence": "additional", "affiliation": []}], "member": "1086", "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-07-1267", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T14:43:45Z", "timestamp": 1482504225000}, "score": 32.23196, "issued": {"date-parts": [[2007, 10, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 10, 15]]}, "issue": "20"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-07-1267", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T17:55:00Z", "timestamp": 1574704500045}, "reference-count": 116, "publisher": "Bioscientifica", "issue": "12", "content-domain": {"domain": ["erc.bioscientifica.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2016, 12]]}, "abstract": "<jats:p>Androgen receptor splice variants are alternatively spliced variants of androgen receptor, which are C-terminally truncated and lack the canonical ligand-binding domain. Accumulating evidence has indicated a significant role of androgen receptor splice variants in mediating resistance of castration-resistant prostate cancer to current therapies and in predicting therapeutic responses. As such, there is an urgent need to target androgen receptor splicing variants for more effective treatment of castration-resistant prostate cancer. Identification of precise and critical targeting points to deactivate androgen receptor splicing variants relies on a deep understanding of how they are generated and the mechanisms of their action. In this review, we will focus on the emerging data on their generation, clinical significance and mechanisms of action as well as the therapeutic influence of these findings.</jats:p>", "DOI": "10.1530/erc-16-0298", "type": "journal-article", "created": {"date-parts": [[2016, 10, 5]], "date-time": "2016-10-05T01:29:26Z", "timestamp": 1475630966000}, "page": "T199-T210", "update-policy": "http://dx.doi.org/10.1530/crossmarkpolicy-1", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Emerging data on androgen receptor splice variants in prostate cancer"], "prefix": "10.1530", "volume": "23", "author": [{"given": "Subing", "family": "Cao", "sequence": "first", "affiliation": []}, {"given": "Yang", "family": "Zhan", "sequence": "additional", "affiliation": []}, {"given": "Yan", "family": "Dong", "sequence": "additional", "affiliation": []}], "member": "416", "reference": [{"key": "2016111120035850000_23.12.T199.1", "DOI": "10.1016/j.cell.2015.10.025", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.2", "DOI": "10.1111/j.1432-1033.2004.04395.x", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.3", "DOI": "10.1210/me.2009-0188", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.4", "DOI": "10.1016/j.ccr.2010.04.027", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.5", "DOI": "10.1001/jamaoncol.2015.1341", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.6", "DOI": "10.1056/NEJMoa1315815", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.7", "DOI": "10.1038/nature13229", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.8", "DOI": "10.1200/JCO.2007.15.9749", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.9", "DOI": "10.1158/0008-5472.CAN-08-3667", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.10", "DOI": "10.1038/onc.2009.243", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.11", "DOI": "10.1002/pros.22649", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.12", "DOI": "10.18632/oncotarget.2924", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.13", "doi-asserted-by": "crossref", "first-page": "1277", "DOI": "10.1002/ijc.27754", "article-title": "20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor", "volume": "132", "author": "Cao", "year": "2013", "journal-title": "International Journal of Cancer"}, {"key": "2016111120035850000_23.12.T199.14", "DOI": "10.18632/oncotarget.1802", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.15", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/B978-0-12-417197-8.00011-0", "article-title": "Constitutive activity of the androgen receptor", "volume": "70", "author": "Chan", "year": "2014", "journal-title": "Advances in Pharmacology"}, {"key": "2016111120035850000_23.12.T199.16", "DOI": "10.1074/jbc.M112.352930", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.17", "DOI": "10.1093/nar/gkv262", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.18", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1186/1476-4598-9-89", "article-title": "Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells", "volume": "9", "author": "Chen", "year": "2010", "journal-title": "Molecular Cancer"}, {"key": "2016111120035850000_23.12.T199.19", "DOI": "10.1038/emboj.2011.154", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.20", "DOI": "10.1371/journal.pone.0063466", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.21", "DOI": "10.1074/jbc.M114.553818", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.22", "DOI": "10.1158/0008-5472.CAN-11-1417", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.23", "DOI": "10.1056/NEJMoa1014618", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.24", "DOI": "10.1158/1078-0432.CCR-14-1358", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.25", "DOI": "10.1158/0008-5472.CAN-08-0594", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.26", "DOI": "10.1158/0008-5472.CAN-06-0411", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.27", "DOI": "10.1200/JCO.2010.33.7675", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.28", "DOI": "10.1016/j.eururo.2014.05.005", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.29", "DOI": "10.1016/j.ctrv.2013.09.011", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.30", "DOI": "10.1074/jbc.M610447200", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.31", "DOI": "10.1158/0008-5472.CAN-15-2186", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.32", "DOI": "10.1016/S1470-2045(12)70379-0", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.33", "DOI": "10.1200/JCO.2002.10.018", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.34", "DOI": "10.1158/0008-5472.CAN-08-3795", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.35", "DOI": "10.1021/jm040202w", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.36", "DOI": "10.1073/pnas.1421415111", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.37", "DOI": "10.1371/journal.pone.0019059", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.38", "DOI": "10.1158/0008-5472.CAN-08-2764", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.39", "DOI": "10.1002/pros.21382", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.40", "DOI": "10.1158/0008-5472.CAN-11-3892", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.41", "DOI": "10.1210/en.2007-0446", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.42", "doi-asserted-by": "crossref", "first-page": "588", "DOI": "10.7150/ijbs.8671", "article-title": "Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer", "volume": "10", "author": "Kahn", "year": "2014", "journal-title": "International Research Journal of Biological Sciences"}, {"key": "2016111120035850000_23.12.T199.43", "doi-asserted-by": "crossref", "first-page": "e0126270", "DOI": "10.1371/journal.pone.0126270", "article-title": "Mutation of androgen receptor N-terminal phosphorylation site Tyr-267 leads to inhibition of nuclear translocation and DNA binding", "volume": "10", "author": "Karaca", "year": "2015", "journal-title": "PLoS ONE"}, {"key": "2016111120035850000_23.12.T199.44", "DOI": "10.1158/1078-0432.CCR-15-2119", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.45", "DOI": "10.1158/1078-0432.CCR-08-2660", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.46", "doi-asserted-by": "crossref", "first-page": "27440", "DOI": "10.18632/oncotarget.4578", "article-title": "Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo", "volume": "6", "author": "Kwegyir-Afful", "year": "2015", "journal-title": "Oncotarget"}, {"key": "2016111120035850000_23.12.T199.47", "DOI": "10.1158/0008-5472.CAN-10-1998", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.48", "doi-asserted-by": "crossref", "first-page": "6458", "DOI": "10.1021/jm500802j", "article-title": "Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor", "volume": "57", "author": "Li", "year": "2014", "journal-title": "Journal of Medicinal Chemistry"}, {"key": "2016111120035850000_23.12.T199.49", "doi-asserted-by": "crossref", "first-page": "1400", "DOI": "10.1002/pros.22855", "article-title": "Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors", "volume": "74", "author": "Li", "year": "2014", "journal-title": "Prostate"}, {"key": "2016111120035850000_23.12.T199.50", "DOI": "10.1158/0008-5472.CAN-12-3630", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.51", "DOI": "10.1371/journal.pone.0031213", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.52", "DOI": "10.1038/onc.2011.637", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.53", "doi-asserted-by": "crossref", "first-page": "20474", "DOI": "10.18632/oncotarget.4105", "article-title": "Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression", "volume": "6", "author": "Li", "year": "2015", "journal-title": "Oncotarget"}, {"key": "2016111120035850000_23.12.T199.54", "first-page": "33743", "article-title": "AR-v7 protein expression is regulated by protein kinase and phosphatase", "volume": "6", "author": "Li", "year": "2015", "journal-title": "Oncotarget"}, {"key": "2016111120035850000_23.12.T199.55", "first-page": "32210", "article-title": "Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer", "volume": "7", "author": "Liu", "year": "2016", "journal-title": "Oncotarget"}, {"key": "2016111120035850000_23.12.T199.56", "DOI": "10.1158/0008-5472.CAN-08-2038", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.57", "DOI": "10.1002/pros.23015", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.58", "first-page": "288", "article-title": "MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand", "volume": "6", "author": "Liu", "year": "2015", "journal-title": "Oncotarget"}, {"key": "2016111120035850000_23.12.T199.59", "DOI": "10.1158/1078-0432.CCR-13-3296", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.60", "DOI": "10.1038/onc.2013.284", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.61", "DOI": "10.1593/neo.13784", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.62", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1016/j.juro.2014.08.043", "article-title": "The cistrome and gene signature of androgen receptor splice variants in castration-resistant prostate cancer cells", "volume": "193", "author": "Lu", "year": "2014", "journal-title": "Journal of Urology"}, {"key": "2016111120035850000_23.12.T199.63", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1038/nrurol.2015.13", "article-title": "Are androgen receptor variants a substitute for the full-length receptor?", "volume": "12", "author": "Lu", "year": "2015", "journal-title": "Nature Reviews Urology"}, {"key": "2016111120035850000_23.12.T199.64", "doi-asserted-by": "crossref", "first-page": "628", "DOI": "10.1016/j.molonc.2014.10.014", "article-title": "N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy", "volume": "9", "author": "Martin", "year": "2015", "journal-title": "Molecular Oncology"}, {"key": "2016111120035850000_23.12.T199.65", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1016/bs.acr.2015.03.001", "article-title": "Exploitation of the androgen receptor to overcome taxane resistance in advanced prostate cancer", "volume": "127", "author": "Martin", "year": "2015", "journal-title": "Advances in Cancer Research"}, {"key": "2016111120035850000_23.12.T199.66", "DOI": "10.1158/0008-5472.CAN-15-2078", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.67", "DOI": "10.1124/mol.110.064790", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.68", "DOI": "10.1158/1538-7445.AM2013-5066", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.69", "DOI": "10.1002/pros.22566", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.70", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1016/j.clgc.2015.12.030", "article-title": "Diving into cabazitaxel\u2019s mode of action: more than a taxane for the treatment of castration-resistant prostate cancer patients", "volume": "14", "author": "Mellado", "year": "2016", "journal-title": "Clinical Genitourinary Cancer"}, {"key": "2016111120035850000_23.12.T199.71", "DOI": "10.1126/science.aab0917", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.72", "DOI": "10.1158/1078-0432.CCR-11-0728", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.73", "DOI": "10.1093/emboj/19.3.359", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.74", "DOI": "10.1172/JCI66398", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.75", "DOI": "10.1158/1535-7163.MCT-14-1057", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.76", "DOI": "10.1158/1535-7163.MCT-13-0027", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.77", "DOI": "10.1021/jm501239f", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.78", "DOI": "10.1073/pnas.1308587110", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.79", "DOI": "10.1016/j.eururo.2015.07.007", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.80", "DOI": "10.1210/me.2012-1165", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.81", "DOI": "10.1021/jm400048v", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.82", "doi-asserted-by": "crossref", "first-page": "7654", "DOI": "10.1038/srep07654", "article-title": "Constitutively active AR-V7 plays an essential role in the development and progression of castration-resistant prostate cancer", "volume": "5", "author": "Qu", "year": "2015", "journal-title": "Scientific Reports"}, {"key": "2016111120035850000_23.12.T199.83", "DOI": "10.1038/onc.2011.273", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.84", "DOI": "10.1016/j.cell.2015.05.001", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.85", "DOI": "10.1056/NEJMoa1209096", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.86", "DOI": "10.1158/0008-5472.CAN_10-3398", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.87", "DOI": "10.1074/jbc.M302460200", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.88", "DOI": "10.1056/NEJMoa1207506", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.89", "DOI": "10.1016/j.steroids.2012.12.013", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.90", "doi-asserted-by": "crossref", "first-page": "31997", "DOI": "10.18632/oncotarget.5585", "article-title": "Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells", "volume": "6", "author": "Shafi", "year": "2015", "journal-title": "Oncotarget"}, {"key": "2016111120035850000_23.12.T199.91", "doi-asserted-by": "crossref", "first-page": "e98566", "DOI": "10.1371/journal.pone.0098566", "article-title": "Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARDeltaLBD-signalling in human prostate cancer cells", "volume": "9", "author": "Streicher", "year": "2014", "journal-title": "PLoS ONE"}, {"key": "2016111120035850000_23.12.T199.92", "DOI": "10.1074/jbc.M113.492140", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.93", "DOI": "10.1093/carcin/bgv040", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.94", "DOI": "10.1172/JCI41824", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.95", "DOI": "10.1158/0008-5472.CAN-13-2876", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.96", "DOI": "10.1126/science.1168175", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.97", "DOI": "10.1242/jcs.096792", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.98", "doi-asserted-by": "crossref", "first-page": "3821", "DOI": "10.1016/j.ejca.2013.09.026", "article-title": "Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer", "volume": "49", "author": "van Soest", "year": "2013", "journal-title": "European Journal of Cancer"}, {"key": "2016111120035850000_23.12.T199.99", "DOI": "10.1379/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.100", "DOI": "10.1016/j.molcel.2007.05.041", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.101", "DOI": "10.1016/j.cell.2009.04.056", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.102", "DOI": "10.1074/jbc.M206061200", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.103", "DOI": "10.1073/pnas.1012443107", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.104", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1016/j.eururo.2016.03.049", "article-title": "Analytical validation and clinical qualification of a new immunohistochemical assay for androgen receptor splice variant-7 protein expression in metastatic castration-resistant prostate cancer.", "volume": "70", "author": "Welti", "year": "2016", "journal-title": "European Urology"}, {"key": "2016111120035850000_23.12.T199.105", "DOI": "10.1093/nar/gkt1382", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.106", "DOI": "10.1158/0008-5472.CAN-15-0381", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.107", "DOI": "10.1158/1078-0432.CCR-14-1108", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.108", "DOI": "10.1593/neo.111436", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.109", "DOI": "10.1074/jbc.M111.265124", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.110", "DOI": "10.1158/1078-0432.CCR-14-0292", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.111", "DOI": "10.3390/ijms130911530", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.112", "DOI": "10.1002/ijc.28202", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.113", "DOI": "10.18632/oncotarget.4396", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.114", "DOI": "10.1371/journal.pone.0027970", "doi-asserted-by": "publisher"}, {"key": "2016111120035850000_23.12.T199.115", "first-page": "15481", "article-title": "Regulation of androgen receptor splice variant AR3 by PCGEM1", "volume": "7", "author": "Zhang", "year": "2016", "journal-title": "Oncotarget"}, {"key": "2016111120035850000_23.12.T199.116", "DOI": "10.1158/0008-5472.CAN-10-0585", "doi-asserted-by": "publisher"}], "container-title": ["Endocrine-Related Cancer"], "link": [{"URL": "https://erc.bioscientifica.com/view/journals/erc/23/12/T199.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 14]], "date-time": "2019-09-14T08:12:56Z", "timestamp": 1568448776000}, "score": 31.538492, "issued": {"date-parts": [[2016, 12]]}, "references-count": 116, "journal-issue": {"issue": "12"}, "URL": "http://dx.doi.org/10.1530/erc-16-0298", "relation": {"cites": []}, "ISSN": ["1351-0088", "1479-6821"], "issn-type": [{"value": "1351-0088", "type": "print"}, {"value": "1479-6821", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T14:13:16Z", "timestamp": 1575468796941}, "reference-count": 86, "publisher": "Wiley", "issue": "17", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 494, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000054", "name": "National Cancer Institute", "doi-asserted-by": "crossref", "award": ["P01-CA77739"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer"], "published-print": {"date-parts": [[2014, 9, 1]]}, "DOI": "10.1002/cncr.28675", "type": "journal-article", "created": {"date-parts": [[2014, 4, 25]], "date-time": "2014-04-25T19:20:40Z", "timestamp": 1398453640000}, "page": "2628-2637", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Concept and viability of androgen annihilation for advanced prostate cancer"], "prefix": "10.1002", "volume": "120", "author": [{"given": "James L.", "family": "Mohler", "sequence": "first", "affiliation": [{"name": "Department of Urology; Roswell Park Cancer Institute; Buffalo New York"}, {"name": "Department of Urology; State University of New York at Buffalo School of Medicine and Biotechnology; Buffalo New York"}]}], "member": "311", "published-online": {"date-parts": [[2014, 4, 25]]}, "reference": [{"key": "10.1002/cncr.28675-BIB0001|cncr28675-cit-0001", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.3322/caac.21166", "article-title": "Cancer statistics, 2013", "volume": "63", "author": "Siegel", "year": "2013", "journal-title": "CA Cancer J Clin."}, {"key": "10.1002/cncr.28675-BIB0002|cncr28675-cit-0002", "first-page": "293", "article-title": "Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate", "volume": "1", "author": "Huggins", "year": "1941", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0003|cncr28675-cit-0003", "doi-asserted-by": "crossref", "first-page": "4333", "DOI": "10.1200/JCO.2008.16.5845", "article-title": "Diabetes and mortality in men with locally advanced prostate cancer", "volume": "26", "author": "Smith", "year": "2008", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0004|cncr28675-cit-0004", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1210/jcem.87.2.8299", "article-title": "Changes in body composition during androgen deprivation therapy for prostate cancer", "volume": "87", "author": "Smith", "year": "2002", "journal-title": "J Clin Endocrinol Metab."}, {"key": "10.1002/cncr.28675-BIB0005|cncr28675-cit-0005", "doi-asserted-by": "crossref", "first-page": "2420", "DOI": "10.1200/JCO.2006.09.3369", "article-title": "Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions", "volume": "25", "author": "D'Amico", "year": "2007", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0006|cncr28675-cit-0006", "doi-asserted-by": "crossref", "first-page": "1596", "DOI": "10.1200/JCO.2006.10.1949", "article-title": "Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline", "volume": "25", "author": "Loblaw", "year": "2007", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0007|cncr28675-cit-0007", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1158/1078-0432.CCR-1146-03", "article-title": "The androgen axis in recurrent prostate cancer", "volume": "10", "author": "Mohler", "year": "2004", "journal-title": "Clin Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0008|cncr28675-cit-0008", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1038/nm972", "article-title": "Molecular determinants of resistance to antiandrogen therapy", "volume": "10", "author": "Chen", "year": "2004", "journal-title": "Nat Med."}, {"key": "10.1002/cncr.28675-BIB0009|cncr28675-cit-0009", "doi-asserted-by": "crossref", "first-page": "4653", "DOI": "10.1158/1078-0432.CCR-05-0525", "article-title": "Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer", "volume": "11", "author": "Titus", "year": "2005", "journal-title": "Clin Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0010|cncr28675-cit-0010", "doi-asserted-by": "crossref", "first-page": "2815", "DOI": "10.1158/0008-5472.CAN-05-4000", "article-title": "Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer", "volume": "66", "author": "Stanbrough", "year": "2006", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0011|cncr28675-cit-0011", "doi-asserted-by": "crossref", "first-page": "6407", "DOI": "10.1158/0008-5472.CAN-07-5997", "article-title": "Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer", "volume": "68", "author": "Locke", "year": "2008", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0012|cncr28675-cit-0012", "doi-asserted-by": "crossref", "first-page": "13728", "DOI": "10.1073/pnas.1107898108", "article-title": "Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer", "volume": "108", "author": "Chang", "year": "2011", "journal-title": "Proc Natl Acad Sci U S A."}, {"key": "10.1002/cncr.28675-BIB0013|cncr28675-cit-0013", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1016/j.jsbmb.2009.03.011", "article-title": "Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts", "volume": "115", "author": "Locke", "year": "2009", "journal-title": "J Steroid Biochem Mol Biol."}, {"key": "10.1002/cncr.28675-BIB0014|cncr28675-cit-0014", "first-page": "390", "article-title": "Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model", "volume": "70", "author": "Leon", "year": "2010", "journal-title": "Prostate."}, {"key": "10.1002/cncr.28675-BIB0015|cncr28675-cit-0015", "doi-asserted-by": "crossref", "first-page": "5844", "DOI": "10.1158/1078-0432.CCR-11-0644", "article-title": "Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone", "volume": "17", "author": "Mohler", "year": "2011", "journal-title": "Clin Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0016|cncr28675-cit-0016", "doi-asserted-by": "crossref", "first-page": "1486", "DOI": "10.1158/0008-5472.CAN-10-1343", "article-title": "Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer", "volume": "71", "author": "JL", "year": "2011", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0017|cncr28675-cit-0017", "doi-asserted-by": "crossref", "first-page": "1074", "DOI": "10.1016/j.cell.2013.07.029", "article-title": "A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer", "volume": "154", "author": "KH", "year": "2013", "journal-title": "Cell"}, {"key": "10.1002/cncr.28675-BIB0018|cncr28675-cit-0018", "doi-asserted-by": "crossref", "first-page": "472", "DOI": "10.1016/S1470-2045(06)70700-8", "article-title": "Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy", "volume": "7", "author": "Messing", "year": "2006", "journal-title": "Lancet Oncol."}, {"key": "10.1002/cncr.28675-BIB0019|cncr28675-cit-0019", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/S0140-6736(02)09408-4", "article-title": "Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial", "volume": "360", "author": "Bolla", "year": "2002", "journal-title": "Lancet."}, {"key": "10.1002/cncr.28675-BIB0020|cncr28675-cit-0020", "doi-asserted-by": "crossref", "first-page": "1285", "DOI": "10.1016/j.ijrobp.2004.08.047", "article-title": "Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31", "volume": "61", "author": "Pilepich", "year": "2005", "journal-title": "Int J Radiat Oncol Biol Phys."}, {"key": "10.1002/cncr.28675-BIB0021|cncr28675-cit-0021", "doi-asserted-by": "crossref", "first-page": "3972", "DOI": "10.1200/JCO.2003.11.023", "article-title": "Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02", "volume": "21", "author": "Hanks", "year": "2003", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0022|cncr28675-cit-0022", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/j.eururo.2009.07.049", "article-title": "Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature", "volume": "57", "author": "Abrahamsson", "year": "2010", "journal-title": "Eur Urol."}, {"key": "10.1002/cncr.28675-BIB0023|cncr28675-cit-0023", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1002/pros.2990050102", "article-title": "The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer", "volume": "5", "author": "Isaacs", "year": "1984", "journal-title": "Prostate."}, {"key": "10.1002/cncr.28675-BIB0024|cncr28675-cit-0024", "first-page": "5070", "article-title": "Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma", "volume": "41", "author": "Isaacs", "year": "1981", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0025|cncr28675-cit-0025", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1038/6495", "article-title": "A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase", "volume": "5", "author": "Craft", "year": "1999", "journal-title": "Nat Med."}, {"key": "10.1002/cncr.28675-BIB0026|cncr28675-cit-0026", "first-page": "2892", "article-title": "Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen", "volume": "61", "author": "Gregory", "year": "2001", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0027|cncr28675-cit-0027", "doi-asserted-by": "crossref", "first-page": "1393", "DOI": "10.1056/NEJM199505253322101", "article-title": "Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer", "volume": "332", "author": "Taplin", "year": "1995", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0028|cncr28675-cit-0028", "doi-asserted-by": "crossref", "first-page": "888", "DOI": "10.1016/S0022-5347(17)49273-1", "article-title": "Optimal testosterone concentration for the treatment of prostatic cancer", "volume": "133", "author": "Trachtenberg", "year": "1985", "journal-title": "J Urol."}, {"key": "10.1002/cncr.28675-BIB0029|cncr28675-cit-0029", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1200/JCO.2010.33.7675", "article-title": "Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone", "volume": "30", "author": "Efstathiou", "year": "2012", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0030|cncr28675-cit-0030", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/j.ccr.2005.01.027", "article-title": "Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen", "volume": "7", "author": "Drake", "year": "2005", "journal-title": "Cancer Cell."}, {"key": "10.1002/cncr.28675-BIB0031|cncr28675-cit-0031", "first-page": "1002", "article-title": "Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice", "volume": "70", "author": "Arredouani", "year": "2010", "journal-title": "Prostate."}, {"key": "10.1002/cncr.28675-BIB0032|cncr28675-cit-0032", "doi-asserted-by": "crossref", "first-page": "14565", "DOI": "10.1073/pnas.251140998", "article-title": "T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer", "volume": "98", "author": "Mercader", "year": "2001", "journal-title": "Proc Natl Acad Sci U S A."}, {"key": "10.1002/cncr.28675-BIB0033|cncr28675-cit-0033", "doi-asserted-by": "crossref", "first-page": "4957", "DOI": "10.2741/2441", "article-title": "Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer", "volume": "12", "author": "Aragon-Ching", "year": "2007", "journal-title": "Front Biosci."}, {"key": "10.1002/cncr.28675-BIB0034|cncr28675-cit-0034", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1056/NEJMoa1001294", "article-title": "Sipuleucel-T immunotherapy for castration-resistant prostate cancer", "volume": "363", "author": "Kantoff", "year": "2010", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0035|cncr28675-cit-0035", "doi-asserted-by": "crossref", "first-page": "1074", "DOI": "10.1002/cncr.1990.66.s5.1074", "article-title": "A controlled trial of castration with and without nilutamide in metastatic prostatic carcinoma", "volume": "66", "author": "Beland", "year": "1990", "journal-title": "Cancer."}, {"key": "10.1002/cncr.28675-BIB0036|cncr28675-cit-0036", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1056/NEJM198908173210702", "article-title": "A controlled trial of leuprolide with and without flutamide in prostatic carcinoma", "volume": "321", "author": "Crawford", "year": "1989", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0037|cncr28675-cit-0037", "doi-asserted-by": "crossref", "first-page": "1036", "DOI": "10.1056/NEJM199810083391504", "article-title": "Bilateral orchiectomy with or without flutamide for metastatic prostate cancer", "volume": "339", "author": "Eisenberger", "year": "1998", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0038|cncr28675-cit-0038", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/0090-4295(93)90634-M", "article-title": "Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853)", "volume": "42", "author": "Denis", "year": "1993", "journal-title": "Urology."}, {"key": "10.1002/cncr.28675-BIB0039|cncr28675-cit-0039", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1046/j.1464-410X.1997.d01-6840.x", "article-title": "Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial", "volume": "79", "author": "The Medical Research Council Prostate Cancer Working Party Investigators Group", "year": "1997", "journal-title": "Br J Urol."}, {"key": "10.1002/cncr.28675-BIB0040|cncr28675-cit-0040", "doi-asserted-by": "crossref", "first-page": "1781", "DOI": "10.1056/NEJM199912093412401", "article-title": "Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer", "volume": "341", "author": "Messing", "year": "1999", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0041|cncr28675-cit-0041", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1200/JCO.2007.14.2042", "article-title": "Role of androgen deprivation therapy for node-positive prostate cancer", "volume": "27", "author": "Wong", "year": "2009", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0042|cncr28675-cit-0042", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1097/01.ju.0000049032.38743.c7", "article-title": "Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?", "volume": "169", "author": "Bader", "year": "2003", "journal-title": "J Urol."}, {"key": "10.1002/cncr.28675-BIB0043|cncr28675-cit-0043", "doi-asserted-by": "crossref", "first-page": "895", "DOI": "10.1056/NEJMoa1201546", "article-title": "Intermittent androgen suppression for rising PSA level after radiotherapy", "volume": "367", "author": "Crook", "year": "2012", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0044|cncr28675-cit-0044", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1634/theoncologist.5-1-45", "article-title": "Intermittent androgen deprivation in prostate cancer patients: factors predictive of prolonged time off therapy", "volume": "5", "author": "Strum", "year": "2000", "journal-title": "Oncologist."}, {"key": "10.1002/cncr.28675-BIB0045|cncr28675-cit-0045", "doi-asserted-by": "crossref", "first-page": "1642", "DOI": "10.1016/S0022-5347(01)66734-X", "article-title": "Combination finasteride and flutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects", "volume": "154", "author": "Fleshner", "year": "1995", "journal-title": "J Urol."}, {"issue": "suppl 2", "key": "10.1002/cncr.28675-BIB0046|cncr28675-cit-0046", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1159/000474400", "article-title": "Treatment of advanced prostate cancer with the combination of finasteride plus flutamide: early results", "volume": "24", "author": "Fleshner", "year": "1993", "journal-title": "Eur Urol."}, {"key": "10.1002/cncr.28675-BIB0047|cncr28675-cit-0047", "doi-asserted-by": "crossref", "first-page": "1928", "DOI": "10.1016/S0022-5347(17)37086-6", "article-title": "Sequential androgen blockade: a biological study in the inhibition of prostatic growth", "volume": "148", "author": "Fleshner", "year": "1992", "journal-title": "J Urol."}, {"issue": "2", "key": "10.1002/cncr.28675-BIB0048|cncr28675-cit-0048", "first-page": "CD001526", "article-title": "Maximal androgen blockade for advanced prostate cancer", "author": "Schmitt", "year": "2000", "journal-title": "Cochrane Database Syst Rev."}, {"key": "10.1002/cncr.28675-BIB0049|cncr28675-cit-0049", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1634/theoncologist.6-2-177", "article-title": "Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients", "volume": "6", "author": "Leibowitz", "year": "2001", "journal-title": "Oncologist."}, {"key": "10.1002/cncr.28675-BIB0050|cncr28675-cit-0050", "author": "Strum", "first-page": "353a", "year": "1999", "article-title": "Intermittent androgen deprivation (IAD) with finasteride (F) given during the induction and maintenance periods results in prolonged time off IAD in patients with localized prostate cancer (LPC)", "journal-title": "Proc Am Soc Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0051|cncr28675-cit-0051", "doi-asserted-by": "crossref", "first-page": "1995", "DOI": "10.1056/NEJMoa1014618", "article-title": "Abiraterone and increased survival in metastatic prostate cancer", "volume": "364", "author": "Bono", "year": "2011", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0052|cncr28675-cit-0052", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1200/JCO.2012.48.6431", "article-title": "Targeted androgen pathway suppression in localized prostate cancer: a pilot study", "volume": "32", "author": "Mostaghel", "year": "2014", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0053|cncr28675-cit-0053", "first-page": "374", "article-title": "Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors", "volume": "32", "author": "DeWys", "year": "1972", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0054|cncr28675-cit-0054", "first-page": "2259", "article-title": "Tumor heterogeneity", "volume": "44", "author": "Heppner", "year": "1984", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0055|cncr28675-cit-0055", "doi-asserted-by": "crossref", "first-page": "1585", "DOI": "10.1016/S0022-5347(05)66353-7", "article-title": "The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer", "volume": "165", "author": "Tomera", "year": "2001", "journal-title": "J Urol."}, {"key": "10.1002/cncr.28675-BIB0056|cncr28675-cit-0056", "first-page": "275", "article-title": "Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone", "volume": "4", "author": "Garnick", "year": "2000", "journal-title": "Mol Urol."}, {"key": "10.1002/cncr.28675-BIB0057|cncr28675-cit-0057", "doi-asserted-by": "crossref", "first-page": "1670", "DOI": "10.1097/00005392-200204000-00021", "article-title": "A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer", "volume": "167", "author": "Trachtenberg", "year": "2002", "journal-title": "J Urol."}, {"key": "10.1002/cncr.28675-BIB0058|cncr28675-cit-0058", "doi-asserted-by": "crossref", "first-page": "744", "DOI": "10.1002/1097-0142(1984)54:4<744::AID-CNCR2820540426>3.0.CO;2-P", "article-title": "Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy", "volume": "54", "author": "Sogani", "year": "1984", "journal-title": "Cancer."}, {"key": "10.1002/cncr.28675-BIB0059|cncr28675-cit-0059", "doi-asserted-by": "crossref", "first-page": "1165", "DOI": "10.1210/endo-126-2-1165", "article-title": "Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone", "volume": "126", "author": "Grino", "year": "1990", "journal-title": "Endocrinology."}, {"key": "10.1002/cncr.28675-BIB0060|cncr28675-cit-0060", "doi-asserted-by": "crossref", "first-page": "1074", "DOI": "10.1111/j.1464-410X.2010.09319.x", "article-title": "Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years", "volume": "105", "author": "Iversen", "year": "2010", "journal-title": "BJU Int."}, {"key": "10.1002/cncr.28675-BIB0061|cncr28675-cit-0061", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1126/science.1168175", "article-title": "Development of a second-generation antiandrogen for treatment of advanced prostate cancer", "volume": "324", "author": "Tran", "year": "2009", "journal-title": "Science."}, {"key": "10.1002/cncr.28675-BIB0062|cncr28675-cit-0062", "doi-asserted-by": "crossref", "first-page": "1187", "DOI": "10.1056/NEJMoa1207506", "article-title": "Increased survival with enzalutamide in prostate cancer after chemotherapy", "volume": "367", "author": "Scher", "year": "2012", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0063|cncr28675-cit-0063", "doi-asserted-by": "crossref", "first-page": "1494", "DOI": "10.1158/0008-5472.CAN-11-3948", "article-title": "ARN-509: a novel antiandrogen for prostate cancer treatment", "volume": "72", "author": "Clegg", "year": "2012", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0064|cncr28675-cit-0064", "doi-asserted-by": "crossref", "first-page": "2179", "DOI": "10.1210/jc.2003-030330", "article-title": "Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor", "volume": "89", "author": "Clark", "year": "2004", "journal-title": "J Clin Endocrinol Metab."}, {"key": "10.1002/cncr.28675-BIB0065|cncr28675-cit-0065", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1016/j.juro.2008.10.014", "article-title": "Phase II study of dutasteride for recurrent prostate cancer during androgen deprivation therapy", "volume": "181", "author": "Shah", "year": "2009", "journal-title": "J Urol."}, {"key": "10.1002/cncr.28675-BIB0066|cncr28675-cit-0066", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1159/000019546", "article-title": "Maximal androgen blockade: final analysis of EORTC phase III trial 30853", "volume": "33", "author": "Denis", "year": "1998", "journal-title": "Eur Urol."}, {"key": "10.1002/cncr.28675-BIB0067|cncr28675-cit-0067", "doi-asserted-by": "crossref", "first-page": "1088", "DOI": "10.1016/S0959-8049(05)80293-X", "article-title": "Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer", "volume": "29A", "author": "Boccardo", "year": "1993", "journal-title": "Eur J Cancer."}, {"key": "10.1002/cncr.28675-BIB0068|cncr28675-cit-0068", "doi-asserted-by": "crossref", "first-page": "1031", "DOI": "10.1097/00000658-194512260-00012", "article-title": "Bilateral adrenalectomy in prostatic cancer: clinical features and urinary excretion of 17-ketosteroids and estrogen", "volume": "122", "author": "Huggins", "year": "1945", "journal-title": "Ann Surg."}, {"key": "10.1002/cncr.28675-BIB0069|cncr28675-cit-0069", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1210/jcem-46-3-440", "article-title": "DHT concentrations in human prostate cancer tissue", "volume": "46", "author": "Geller", "year": "1978", "journal-title": "J Clin Endocrinol Metab."}, {"key": "10.1002/cncr.28675-BIB0070|cncr28675-cit-0070", "doi-asserted-by": "crossref", "first-page": "6383", "DOI": "10.1016/j.bmc.2011.08.066", "article-title": "Discovery of orteronel (TAK-700), a napththylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer", "volume": "19", "author": "Kaku", "year": "2011", "journal-title": "Bioorg Med Chem."}, {"key": "10.1002/cncr.28675-BIB0071|cncr28675-cit-0071", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/j.jsbmb.2012.01.001", "article-title": "Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys", "volume": "129", "author": "Yamaoka", "year": "2012", "journal-title": "J Steroid Biochem Mol Biol."}, {"key": "10.1002/cncr.28675-BIB0072|cncr28675-cit-0072", "unstructured": "Takeda Pharmaceutical Company Limited Takeda Announces Unblinding of Phase 3 Study of Orteronel in Patients with Metastatic, Castration-Resistant Prostate Cancer that Progressed Post-Chemotherapy Based on Interim Analysis [press release] http://www.takeda.com/news/2013/20130726_5894.html"}, {"key": "10.1002/cncr.28675-BIB0073|cncr28675-cit-0073", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/j.jsbmb.2004.07.006", "article-title": "Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model", "volume": "92", "author": "Handratta", "year": "2004", "journal-title": "J Steroid Biochem Mol Biol."}, {"key": "10.1002/cncr.28675-BIB0074|cncr28675-cit-0074", "doi-asserted-by": "crossref", "first-page": "2348", "DOI": "10.1158/1535-7163.MCT-08-0230", "article-title": "Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer", "volume": "7", "author": "Vasaitis", "year": "2008", "journal-title": "Mol Cancer Ther."}, {"key": "10.1002/cncr.28675-BIB0075|cncr28675-cit-0075", "doi-asserted-by": "crossref", "first-page": "2022", "DOI": "10.1200/JCO.2008.17.2882", "article-title": "Genomic strategy for targeting therapy in castration-resistant prostate cancer", "volume": "27", "author": "Mendiratta", "year": "2009", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0076|cncr28675-cit-0076", "doi-asserted-by": "crossref", "first-page": "5033", "DOI": "10.1158/0008-5472.CAN-06-3332", "article-title": "Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer", "volume": "67", "author": "Mostaghel", "year": "2007", "journal-title": "Cancer Res."}, {"key": "10.1002/cncr.28675-BIB0077|cncr28675-cit-0077", "doi-asserted-by": "crossref", "first-page": "2565", "DOI": "10.1200/JCO.2010.31.2405", "article-title": "SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer", "volume": "29", "author": "Yang", "year": "2011", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0078|cncr28675-cit-0078", "doi-asserted-by": "crossref", "first-page": "1483", "DOI": "10.1002/pros.22696", "article-title": "The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific", "volume": "73", "author": "Chhipa", "year": "2013", "journal-title": "Prostate."}, {"key": "10.1002/cncr.28675-BIB0079|cncr28675-cit-0079", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1016/j.urolonc.2004.12.014", "article-title": "Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer", "volume": "23", "author": "Salam", "year": "2005", "journal-title": "Urol Oncol."}, {"key": "10.1002/cncr.28675-BIB0080|cncr28675-cit-0080", "doi-asserted-by": "crossref", "first-page": "1470", "DOI": "10.1002/pros.22694", "article-title": "Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5alpha-reductase inhibitors", "volume": "73", "author": "Wu", "year": "2013", "journal-title": "Prostate."}, {"key": "10.1002/cncr.28675-BIB0081|cncr28675-cit-0081", "first-page": "1317", "article-title": "Reduced levels of 5-alpha reductase 2 in adult prostate tissue and implications for BPH therapy", "volume": "71", "author": "Niu", "year": "2011", "journal-title": "Prostate."}, {"key": "10.1002/cncr.28675-BIB0082|cncr28675-cit-0082", "doi-asserted-by": "crossref", "first-page": "3916", "DOI": "10.1200/JCO.2008.18.6486", "article-title": "Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function", "volume": "27", "author": "Chen", "year": "2009", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0083|cncr28675-cit-0083", "doi-asserted-by": "crossref", "first-page": "1250", "DOI": "10.1056/NEJMoa074311", "article-title": "Quality of life and satisfaction with outcome among prostate-cancer survivors", "volume": "358", "author": "Sanda", "year": "2008", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28675-BIB0084|cncr28675-cit-0084", "doi-asserted-by": "crossref", "first-page": "1385", "DOI": "10.1007/s00432-008-0409-z", "article-title": "Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study", "volume": "134", "author": "Arai", "year": "2008", "journal-title": "J Cancer Res Clin Oncol."}, {"key": "10.1002/cncr.28675-BIB0085|cncr28675-cit-0085", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1038/aja.2011.108", "article-title": "Quality of life issues in men undergoing androgen deprivation therapy: a review", "volume": "14", "author": "Casey", "year": "2012", "journal-title": "Asian J Androl."}, {"key": "10.1002/cncr.28675-BIB0086|cncr28675-cit-0086", "doi-asserted-by": "crossref", "first-page": "920", "DOI": "10.1016/S0090-4295(97)00459-7", "article-title": "Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument", "volume": "50", "author": "Esper", "year": "1997", "journal-title": "Urology."}], "container-title": ["Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.28675", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T22:15:38Z", "timestamp": 1565388938000}, "score": 31.518772, "subtitle": ["Androgen Annihilation for Prostate Cancer"], "issued": {"date-parts": [[2014, 4, 25]]}, "references-count": 86, "journal-issue": {"published-print": {"date-parts": [[2014, 9, 1]]}, "issue": "17"}, "URL": "http://dx.doi.org/10.1002/cncr.28675", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0008-543X"], "issn-type": [{"value": "0008-543X", "type": "print"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:20:47Z", "timestamp": 1574493647286}, "reference-count": 40, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1704, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2011]]}, "DOI": "10.1002/pros.21345", "type": "journal-article", "created": {"date-parts": [[2011, 2, 9]], "date-time": "2011-02-09T13:55:44Z", "timestamp": 1297259744000}, "page": "n/a-n/a", "source": "Crossref", "is-referenced-by-count": 1, "title": ["G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells"], "prefix": "10.1002", "author": [{"given": "Jianjun", "family": "Liu", "sequence": "first", "affiliation": []}, {"given": "Hyewon", "family": "Youn", "sequence": "additional", "affiliation": []}, {"given": "Jun", "family": "Yang", "sequence": "additional", "affiliation": []}, {"given": "Ningchao", "family": "Du", "sequence": "additional", "affiliation": []}, {"given": "Jihong", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Hongwei", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Benyi", "family": "Li", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 2, 9]]}, "reference": [{"key": "10.1002/pros.21345-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "8253", "DOI": "10.1200/JCO.2005.03.4777", "article-title": "Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis", "volume": "23", "author": "Scher", "year": "2005", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pros.21345-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "276", "DOI": "10.1210/er.2002-0032", "article-title": "Androgen receptor in prostate cancer", "volume": "25", "author": "Heinlein", "year": "2004", "journal-title": "Endocr Rev"}, {"key": "10.1002/pros.21345-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1038/35094009", "article-title": "The development of androgen-independent prostate cancer", "volume": "1", "author": "Feldman", "year": "2001", "journal-title": "Nat Rev Cancer"}, {"key": "10.1002/pros.21345-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1320", "DOI": "10.1111/j.1464-410X.2005.05526.x", "article-title": "The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor", "volume": "95", "author": "Edwards", "year": "2005", "journal-title": "BJU Int"}, {"key": "10.1002/pros.21345-BIB5|cit5", "first-page": "re2", "article-title": "G proteins in cancer: The prostate cancer paradigm", "volume": "216", "author": "Daaka", "year": "2004", "journal-title": "Sci STKE"}, {"key": "10.1002/pros.21345-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "2941", "DOI": "10.1210/en.2003-1519", "article-title": "Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer", "volume": "145", "author": "Liao", "year": "2004", "journal-title": "Endocrinology"}, {"key": "10.1002/pros.21345-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "4569", "DOI": "10.1038/onc.2008.91", "article-title": "Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers", "volume": "27", "author": "Zhu", "year": "2008", "journal-title": "Oncogene"}, {"key": "10.1002/pros.21345-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "3830", "DOI": "10.1210/en.2002-220240", "article-title": "Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor", "volume": "143", "author": "Pi", "year": "2002", "journal-title": "Endocrinology"}, {"key": "10.1002/pros.21345-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "7981", "DOI": "10.1038/sj.onc.1206735", "article-title": "Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway", "volume": "22", "author": "Lee", "year": "2003", "journal-title": "Oncogene"}, {"key": "10.1002/pros.21345-BIB10|cit10", "first-page": "903", "article-title": "Phosphatidylinositol 3-kinase activity is required for epidermal growth factor to suppress proteolysis", "volume": "13", "author": "Franch", "year": "2002", "journal-title": "J Am Soc Nephrol"}, {"key": "10.1002/pros.21345-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1677/jme.0.0320325", "article-title": "G-protein coupled receptors in lipid rafts and caveolae: How, when and why do they go there", "volume": "32", "author": "Chini", "year": "2004", "journal-title": "J Mol Endocrinol"}, {"key": "10.1002/pros.21345-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "816", "DOI": "10.1016/j.cardiores.2005.10.006", "article-title": "Caveolae modulate excitation-contraction coupling and beta2-adrenergic signaling in adult rat ventricular myocytes", "volume": "69", "author": "Calaghan", "year": "2006", "journal-title": "Cardiovasc Res"}, {"key": "10.1002/pros.21345-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1038/2048", "article-title": "Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells", "volume": "4", "author": "Nasu", "year": "1998", "journal-title": "Nat Med"}, {"key": "10.1002/pros.21345-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "25134", "DOI": "10.1074/jbc.M501186200", "article-title": "Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: Genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice", "volume": "280", "author": "Williams", "year": "2005", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1002/(SICI)1097-0045(19990901)40:4<269::AID-PROS9>3.0.CO;2-6", "article-title": "Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines", "volume": "40", "author": "Pflug", "year": "1999", "journal-title": "Prostate"}, {"key": "10.1002/pros.21345-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "6511", "DOI": "10.1073/pnas.1031672100", "article-title": "The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation", "volume": "100", "author": "Sowa", "year": "2003", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/pros.21345-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "13442", "DOI": "10.1074/jbc.M006598200", "article-title": "Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation", "volume": "276", "author": "Lu", "year": "2001", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "11583", "DOI": "10.1074/jbc.M414423200", "article-title": "Androgen receptor activation by G(s) signaling in prostate cancer cells", "volume": "280", "author": "Kasbohm", "year": "2005", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1038/nrc1753", "article-title": "Oncogenic PI3K deregulates transcription and translation", "volume": "5", "author": "Bader", "year": "2005", "journal-title": "Nat Rev Cancer"}, {"key": "10.1002/pros.21345-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "19080", "DOI": "10.1074/jbc.273.30.19080", "article-title": "Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinasegamma", "volume": "273", "author": "Murga", "year": "1998", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1016/j.steroids.2005.02.015", "article-title": "Requirements for estrogen receptor alpha membrane localization and function", "volume": "70", "author": "Evinger", "year": "2005", "journal-title": "Steroids"}, {"key": "10.1002/pros.21345-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/j.steroids.2004.05.001", "article-title": "Rapid signaling pathway activation by androgens in epithelial and stromal cells", "volume": "69", "author": "Castoria", "year": "2004", "journal-title": "Steroids"}, {"key": "10.1002/pros.21345-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "2181", "DOI": "10.1210/me.2002-0070", "article-title": "The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions", "volume": "16", "author": "Heinlein", "year": "2002", "journal-title": "Mol Endocrinol"}, {"key": "10.1002/pros.21345-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1042/CS20040329", "article-title": "Signal transduction in prostate cancer progression", "volume": "108", "author": "Gioeli", "year": "2005", "journal-title": "Clin Sci (Lond)"}, {"key": "10.1002/pros.21345-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1080/08977190412331279908", "article-title": "Androgen receptor cross-talk with cell signaling pathways", "volume": "22", "author": "Culig", "year": "2004", "journal-title": "Growth Factors"}, {"key": "10.1002/pros.21345-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1016/S0039-128X(98)00084-1", "article-title": "Sex hormone-binding globulin receptor signal transduction proceeds via a G protein", "volume": "64", "author": "Nakhla", "year": "1999", "journal-title": "Steroids"}, {"key": "10.1002/pros.21345-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1016/S0960-0760(99)00070-9", "article-title": "Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane", "volume": "69", "author": "Rosner", "year": "1999", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "10.1002/pros.21345-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1016/S0039-128X(98)00108-1", "article-title": "Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate", "volume": "64", "author": "Rosner", "year": "1999", "journal-title": "Steroids"}, {"key": "10.1002/pros.21345-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "19900", "DOI": "10.1074/jbc.271.33.19900", "article-title": "Activation of the human androgen receptor through a protein kinase A signaling pathway", "volume": "271", "author": "Nazareth", "year": "1996", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "7777", "DOI": "10.1074/jbc.274.12.7777", "article-title": "Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways", "volume": "274", "author": "Sadar", "year": "1999", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "29182", "DOI": "10.1074/jbc.271.46.29182", "article-title": "Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases", "volume": "271", "author": "Li", "year": "1996", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "1618", "DOI": "10.1210/me.14.10.1618", "article-title": "Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin", "volume": "14", "author": "Ozanne", "year": "2000", "journal-title": "Mol Endocrinol"}, {"key": "10.1002/pros.21345-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1091/mbc.11.1.325", "article-title": "Identification of filamin as a novel ligand for caveolin-1: Evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton", "volume": "11", "author": "Stahlhut", "year": "2000", "journal-title": "Mol Biol Cell"}, {"key": "10.1002/pros.21345-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "42992", "DOI": "10.1074/jbc.M306295200", "article-title": "Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src", "volume": "278", "author": "Sun", "year": "2003", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/j.ccr.2006.08.021", "article-title": "Regulation of androgen receptor activity by tyrosine phosphorylation", "volume": "10", "author": "Guo", "year": "2006", "journal-title": "Cancer Cell"}, {"key": "10.1002/pros.21345-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/j.ccr.2004.09.031", "article-title": "HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability", "volume": "6", "author": "Mellinghoff", "year": "2004", "journal-title": "Cancer Cell"}, {"key": "10.1002/pros.21345-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "1922", "DOI": "10.1074/jbc.M311145200", "article-title": "Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling", "volume": "279", "author": "Schrantz", "year": "2004", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.21345-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "2287", "DOI": "10.1158/0008-5472.CAN-04-3250", "article-title": "Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth", "volume": "65", "author": "Cha", "year": "2005", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.21345-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1016/j.coph.2005.03.002", "article-title": "Phosphoinositide 3-kinases as drug targets in cancer", "volume": "5", "author": "Stephens", "year": "2005", "journal-title": "Curr Opin Pharmacol"}, {"key": "10.1002/pros.21345-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "1159", "DOI": "10.1152/physrev.00003.2005", "article-title": "Mammalian G proteins and their cell type specific functions", "volume": "85", "author": "Wettschureck", "year": "2005", "journal-title": "Physiol Rev"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.21345", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T19:34:15Z", "timestamp": 1497900855000}, "score": 31.28619, "issued": {"date-parts": [[2011]]}, "references-count": 40, "URL": "http://dx.doi.org/10.1002/pros.21345", "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:26:27Z", "timestamp": 1574133987678}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "8-9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 8, 1]], "date-time": "2004-08-01T00:00:00Z", "timestamp": 1091318400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Steroids"], "published-print": {"date-parts": [[2004, 8]]}, "DOI": "10.1016/j.steroids.2004.05.011", "type": "journal-article", "created": {"date-parts": [[2004, 8, 5]], "date-time": "2004-08-05T01:24:45Z", "timestamp": 1091669085000}, "page": "549-552", "source": "Crossref", "is-referenced-by-count": 26, "title": ["The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells"], "prefix": "10.1016", "volume": "69", "author": [{"given": "L", "family": "BONACCORSI", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Steroids"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0039-128X(04)00077-7?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0039-128X(04)00077-7?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 5]], "date-time": "2019-02-05T06:23:08Z", "timestamp": 1549347788000}, "score": 30.892653, "issued": {"date-parts": [[2004, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 8]]}, "issue": "8-9"}, "alternative-id": ["S0039-128X(04)00077-7"], "URL": "http://dx.doi.org/10.1016/j.steroids.2004.05.011", "ISSN": ["0039-128X"], "issn-type": [{"value": "0039-128X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:18:35Z", "timestamp": 1574414315324}, "reference-count": 0, "publisher": "WORLD SCIENTIFIC", "isbn-type": [{"value": "9789812705365", "type": "print"}, {"value": "9789812819178", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 3]]}, "DOI": "10.1142/9789812819178_0007", "type": "book-chapter", "created": {"date-parts": [[2010, 2, 24]], "date-time": "2010-02-24T03:56:51Z", "timestamp": 1266983811000}, "page": "281-300", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Androgen Receptor Coactivators in Prostate Cancer"], "prefix": "10.1142", "author": [{"given": "Nancy L.", "family": "Weigel", "sequence": "first", "affiliation": []}, {"given": "Irina U.", "family": "Agoulnik", "sequence": "additional", "affiliation": []}], "member": "219", "published-online": {"date-parts": [[2012, 1, 26]]}, "container-title": ["Nuclear Receptor Coregulators and Human Diseases"], "deposited": {"date-parts": [[2017, 7, 19]], "date-time": "2017-07-19T16:33:58Z", "timestamp": 1500482038000}, "score": 30.46878, "issued": {"date-parts": [[2008, 3]]}, "ISBN": ["9789812705365", "9789812819178"], "references-count": 0, "alternative-id": ["10.1142/9789812819178_0007", "10.1142/6367"], "URL": "http://dx.doi.org/10.1142/9789812819178_0007"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T10:45:45Z", "timestamp": 1575110745224}, "reference-count": 39, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3652, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2005, 9, 1]]}, "DOI": "10.1002/pros.20251", "type": "journal-article", "created": {"date-parts": [[2005, 3, 7]], "date-time": "2005-03-07T21:48:25Z", "timestamp": 1110232105000}, "page": "362-372", "source": "Crossref", "is-referenced-by-count": 29, "title": ["Androgen receptor signaling and vitamin D receptor action in prostate cancer cells"], "prefix": "10.1002", "volume": "64", "author": [{"given": "Shalini", "family": "Murthy", "sequence": "first", "affiliation": []}, {"given": "Irina U.", "family": "Agoulnik", "sequence": "additional", "affiliation": []}, {"given": "Nancy L.", "family": "Weigel", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/pros.20251-BIB1", "author": "Skowronski", "volume": "132", "first-page": "1952", "year": "1993", "journal-title": "Endocrinology", "DOI": "10.1210/endo.132.5.7682937", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB2", "author": "Miller", "volume": "1", "first-page": "997", "year": "1995", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/pros.20251-BIB3", "author": "Veldscholte", "volume": "41", "first-page": "665", "year": "1992", "journal-title": "J Steroid Biochem Mol Biol", "DOI": "10.1016/0960-0760(92)90401-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB4", "author": "Blutt", "volume": "138", "first-page": "1491", "year": "1997", "journal-title": "Endocrinology", "DOI": "10.1210/endo.138.4.5063", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB5", "author": "Zhuang", "volume": "139", "first-page": "1197", "year": "1998", "journal-title": "Endocrinology", "DOI": "10.1210/endo.139.3.5770", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB6", "author": "Hsieh", "volume": "235", "first-page": "539", "year": "1997", "journal-title": "Biochem Biophys Res Commun", "DOI": "10.1006/bbrc.1997.6838", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB7", "author": "Blutt", "volume": "141", "first-page": "10", "year": "2000", "journal-title": "Endocrinology", "DOI": "10.1210/endo.141.1.7289", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB8", "author": "Esquenet", "volume": "28", "first-page": "182", "year": "1996", "journal-title": "Prostate", "DOI": "10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO;2-H", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB9", "author": "Zhao", "volume": "138", "first-page": "3290", "year": "1997", "journal-title": "Endocrinology", "DOI": "10.1210/endo.138.8.5328", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB10", "author": "Zhao", "volume": "140", "first-page": "1205", "year": "1999", "journal-title": "Endocrinology", "DOI": "10.1210/endo.140.3.6561", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB11", "author": "Geck", "volume": "63", "first-page": "211", "year": "1997", "journal-title": "J Steroid Biochem Mol Biol", "DOI": "10.1016/S0960-0760(97)00122-2", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB12", "author": "Geck", "volume": "68", "first-page": "41", "year": "1999", "journal-title": "J Steroid Biochem Mol Biol", "DOI": "10.1016/S0960-0760(98)00165-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB13", "author": "Geck", "volume": "97", "first-page": "10185", "year": "2000", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.97.18.10185", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB14", "author": "Wu", "volume": "57", "first-page": "406", "year": "1994", "journal-title": "Int J Cancer", "DOI": "10.1002/ijc.2910570319", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB15", "author": "McConkey", "volume": "56", "first-page": "5594", "year": "1996", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.20251-BIB16", "author": "Craft", "volume": "5", "first-page": "280", "year": "1999", "journal-title": "Nat Med", "DOI": "10.1038/6495", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB17", "author": "Murthy", "volume": "56", "first-page": "293", "year": "2003", "journal-title": "Prostate", "DOI": "10.1002/pros.10261", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB18", "author": "Li", "volume": "276", "first-page": "20444", "year": "2001", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M010226200", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB19", "author": "Bao", "volume": "23", "first-page": "3350", "year": "2004", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1207461", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB20", "author": "Pettaway", "volume": "2", "first-page": "1627", "year": "1996", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/pros.20251-BIB21", "author": "Thalmann", "volume": "44", "first-page": "91", "year": "2000", "journal-title": "Prostate", "DOI": "10.1002/1097-0045(20000701)44:2<91::AID-PROS1>3.0.CO;2-L", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB22", "author": "Jurutka", "volume": "2", "first-page": "203", "year": "2001", "journal-title": "Rev Endocr Metab Disord", "DOI": "10.1023/A:1010062929140", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB23", "author": "Veldscholte", "volume": "49", "first-page": "341", "year": "1994", "journal-title": "J Steroid Biochem Mol Biol", "DOI": "10.1016/0960-0760(94)90277-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB24", "author": "Geck", "volume": "69", "first-page": "461", "year": "2001", "journal-title": "Am J Hum Genet", "DOI": "10.1086/321968", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB25", "author": "van Bokhoven", "volume": "47", "first-page": "36", "year": "2001", "journal-title": "Prostate", "DOI": "10.1002/pros.1045", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB26", "author": "Peng", "volume": "18", "first-page": "1109", "year": "2004", "journal-title": "Mol Endocrinol", "DOI": "10.1210/me.2003-0344", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB27", "author": "Sramkoski", "volume": "35", "first-page": "403", "year": "1999", "journal-title": "In Vitro Cell Dev Biol Anim", "DOI": "10.1007/s11626-999-0115-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB28", "author": "Gregory", "volume": "58", "first-page": "5718", "year": "1998", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.20251-BIB29", "author": "Cronauer", "volume": "23", "first-page": "3541", "year": "2004", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1207346", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB30", "author": "Feldman", "volume": "141", "first-page": "5", "year": "2000", "journal-title": "Endocrinology", "DOI": "10.1210/endo.141.1.7341", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB31", "author": "Fife", "volume": "120", "first-page": "65", "year": "1997", "journal-title": "Cancer Lett", "DOI": "10.1016/S0304-3835(97)00298-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB32", "author": "Campbell", "volume": "19", "first-page": "15", "year": "1997", "journal-title": "J Mol Endocrinol", "DOI": "10.1677/jme.0.0190015", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB33", "author": "Blutt", "volume": "60", "first-page": "779", "year": "2000", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.20251-BIB34", "author": "Zhao", "volume": "141", "first-page": "2548", "year": "2000", "journal-title": "Endocrinology", "DOI": "10.1210/endo.141.7.7549", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB35", "author": "Zhuang", "volume": "126", "first-page": "83", "year": "1997", "journal-title": "Mol Cell Endocrinol", "DOI": "10.1016/S0303-7207(96)03974-3", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB36", "author": "Zegarra-Moro", "volume": "62", "first-page": "1008", "year": "2002", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.20251-BIB37", "author": "Zhao", "volume": "162", "first-page": "2192", "year": "1999", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(05)68158-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB38", "author": "Zhao", "volume": "6", "first-page": "703", "year": "2000", "journal-title": "Nat Med", "DOI": "10.1038/76287", "doi-asserted-by": "crossref"}, {"key": "10.1002/pros.20251-BIB39", "author": "Yang", "volume": "186", "first-page": "69", "year": "2002", "journal-title": "Mol Cell Endocrinol", "DOI": "10.1016/S0303-7207(01)00671-2", "doi-asserted-by": "crossref"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.20251", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/pros.20251", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 1]], "date-time": "2019-02-01T20:59:08Z", "timestamp": 1549054748000}, "score": 30.201876, "issued": {"date-parts": [[2005, 9, 1]]}, "references-count": 39, "journal-issue": {"published-print": {"date-parts": [[2005, 9, 1]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/pros.20251", "relation": {"cites": []}, "ISSN": ["0270-4137", "1097-0045"], "issn-type": [{"value": "0270-4137", "type": "print"}, {"value": "1097-0045", "type": "electronic"}], "subject": ["Urology", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:59:25Z", "timestamp": 1574690365545}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2014, 10, 1]]}, "DOI": "10.1158/1538-7445.am2014-lb-26", "type": "proceedings-article", "created": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T21:53:01Z", "timestamp": 1430517181000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract LB-26: Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors"], "prefix": "10.1158", "author": [{"given": "Yun", "family": "Qiu", "sequence": "first", "affiliation": []}, {"given": "Feng", "family": "Sun", "sequence": "additional", "affiliation": []}, {"given": "Xi", "family": "Yang", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 9, 30]]}, "event": {"name": "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA"}, "container-title": ["Tumor Biology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2014-LB-26", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T16:04:24Z", "timestamp": 1558195464000}, "score": 29.994959, "issued": {"date-parts": [[2014, 9, 30]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2014-LB-26"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2014-lb-26"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T10:34:19Z", "timestamp": 1574332459942}, "reference-count": 55, "publisher": "Springer Science and Business Media LLC", "issue": "21", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 11, 26]], "date-time": "2007-11-26T00:00:00Z", "timestamp": 1196035200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2008, 5]]}, "DOI": "10.1038/sj.onc.1210955", "type": "journal-article", "created": {"date-parts": [[2007, 11, 26]], "date-time": "2007-11-26T12:54:16Z", "timestamp": 1196081656000}, "page": "2941-2950", "source": "Crossref", "is-referenced-by-count": 44, "title": ["Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression"], "prefix": "10.1038", "volume": "27", "author": [{"given": "G N", "family": "Brooke", "sequence": "first", "affiliation": []}, {"given": "M G", "family": "Parker", "sequence": "additional", "affiliation": []}, {"given": "C L", "family": "Bevan", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 11, 26]]}, "reference": [{"key": "BF1210955_CR1", "doi-asserted-by": "publisher", "first-page": "7959", "DOI": "10.1158/0008-5472.CAN-04-3541", "volume": "65", "author": "I Agoulnik", "year": "2005", "unstructured": "Agoulnik I, Vaid A, Bingman WR, Erdeme H, Frolov A, Smith C et al. (2005). Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res 65: 7959\u20137967.", "journal-title": "Cancer Res"}, {"key": "BF1210955_CR2", "doi-asserted-by": "publisher", "first-page": "25801", "DOI": "10.1074/jbc.M703268200", "volume": "282", "author": "E Askew", "year": "2007", "unstructured": "Askew E, Gampe RJ, Stanley T, Faggart J, Wilson E . (2007). Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone. J Biol Chem 282: 25801\u201325816.", "journal-title": "J Biol Chem"}, {"key": "BF1210955_CR3", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1016/0960-0760(93)90313-L", "volume": "46", "author": "CA Berrevoets", "year": "1993", "unstructured": "Berrevoets CA, Veldscholte J, Mulder E . (1993). Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors. J Steroid Biochem Mol Biol 46: 731\u2013736.", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "BF1210955_CR4", "doi-asserted-by": "publisher", "first-page": "8383", "DOI": "10.1128/MCB.19.12.8383", "volume": "19", "author": "CL Bevan", "year": "1999", "unstructured": "Bevan CL, Hoare S, Claessens F, Heery DM, Parker MG . (1999). The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 19: 8383\u20138396.", "journal-title": "Mol Cell Biol"}, {"key": "BF1210955_CR5", "doi-asserted-by": "publisher", "first-page": "1438", "DOI": "10.1210/me.2003-0313", "volume": "18", "author": "L Callewaert", "year": "2004", "unstructured": "Callewaert L, Verrijdt G, Haelens A, Claessens F . (2004). Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements. Mol Endocrinol 18: 1438\u20131449.", "journal-title": "Mol Endocrinol"}, {"key": "BF1210955_CR6", "doi-asserted-by": "publisher", "first-page": "2745", "DOI": "10.1128/MCB.7.8.2745", "volume": "7", "author": "C Chen", "year": "1987", "unstructured": "Chen C, Okayama H . (1987). High efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745\u20132752.", "journal-title": "Mol Cell Biol"}, {"key": "BF1210955_CR7", "doi-asserted-by": "publisher", "first-page": "719", "DOI": "10.1002/ijc.22365", "volume": "120", "author": "R Chmelar", "year": "2007", "unstructured": "Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM . (2007). Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 120: 719\u2013733.", "journal-title": "Int J Cancer"}, {"key": "BF1210955_CR8", "doi-asserted-by": "publisher", "first-page": "2132", "DOI": "10.1210/me.2003-0375", "volume": "18", "author": "HJ Dubbink", "year": "2004", "unstructured": "Dubbink HJ, Hersmus R, Verma CS, van der Korput HA, Berrevoets CA, van Tol J et al. (2004). Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Mol Endocrinol 18: 2132\u20132150.", "journal-title": "Mol Endocrinol"}, {"key": "BF1210955_CR9", "doi-asserted-by": "publisher", "first-page": "2943", "DOI": "10.1210/me.2005-0231", "volume": "19", "author": "J Duff", "year": "2005", "unstructured": "Duff J, McEwan IJ . (2005). Mutation of histidine 874 in the androgen receptor ligand-binding domain leads to promiscuous ligand activation and altered p160 coactivator interactions. Mol Endocrinol 19: 2943\u20132954.", "journal-title": "Mol Endocrinol"}, {"key": "BF1210955_CR10", "doi-asserted-by": "publisher", "first-page": "8060", "DOI": "10.1074/jbc.M407046200", "volume": "280", "author": "E Estebanez-Perpina", "year": "2005", "unstructured": "Estebanez-Perpina E, Moore JM, Mar E, Delgado-Rodrigues E, Nguyen P, Baxter JD et al. (2005). The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. J Biol Chem 280: 8060\u20138068.", "journal-title": "J Biol Chem"}, {"key": "BF1210955_CR11", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1016/S0090-4295(01)01117-7", "volume": "58", "author": "N Fujimoto", "year": "2001", "unstructured": "Fujimoto N, Mizokami A, Harada S, Matsumoto T . (2001). Different expression of androgen receptor coactivators in human prostate. Urology 58: 289\u2013294.", "journal-title": "Urology"}, {"key": "BF1210955_CR12", "doi-asserted-by": "publisher", "first-page": "1757", "DOI": "10.1038/sj.onc.1209967", "volume": "26", "author": "SC Gamble", "year": "2006", "unstructured": "Gamble SC, Chotai D, Odontiadis M, Dart DA, Brooke GN, Powell SM et al. (2006). Prohibitin, a protein downregulated by androgens, represses androgen receptor activity. Oncogene 26: 1757\u20131768.", "journal-title": "Oncogene"}, {"key": "BF1210955_CR13", "doi-asserted-by": "publisher", "first-page": "3001", "DOI": "10.1200/JCO.2002.10.018", "volume": "20", "author": "EP Gelmann", "year": "2002", "unstructured": "Gelmann EP . (2002). Molecular biology of the androgen receptor. J Clin Oncol 20: 3001\u20133015.", "journal-title": "J Clin Oncol"}, {"key": "BF1210955_CR14", "first-page": "162", "volume": "26", "author": "S Goktas", "year": "1999", "unstructured": "Goktas S, Crawford ED . (1999). Optimal hormonal therapy for advanced prostatic carcinoma. Semin Oncol 26: 162\u2013173.", "journal-title": "Semin Oncol"}, {"key": "BF1210955_CR15", "doi-asserted-by": "publisher", "first-page": "527", "DOI": "10.1002/humu.20044", "volume": "23", "author": "B Gottlieb", "year": "2004", "unstructured": "Gottlieb B, Beitel LK, Wu JH, Trifiro M . (2004). The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 23: 527\u2013533.", "journal-title": "Hum Mutat"}, {"key": "BF1210955_CR16", "first-page": "5718", "volume": "58", "author": "C Gregory", "year": "1998", "unstructured": "Gregory C, Hamil K, Kim D, Hall S, Pretlow T, Mohler J et al. (1998). Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res 58: 5718\u20135724.", "journal-title": "Cancer Res"}, {"key": "BF1210955_CR17", "first-page": "4315", "volume": "61", "author": "CW Gregory", "year": "2001", "unstructured": "Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS et al. (2001). A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61: 4315\u20134319.", "journal-title": "Cancer Res"}, {"key": "BF1210955_CR18", "doi-asserted-by": "publisher", "first-page": "22986", "DOI": "10.1074/jbc.M002807200", "volume": "275", "author": "B He", "year": "2000", "unstructured": "He B, Kemppainen JA, Wilson EM . (2000). FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275: 22986\u201322994.", "journal-title": "J Biol Chem"}, {"key": "BF1210955_CR19", "doi-asserted-by": "publisher", "first-page": "25631", "DOI": "10.1074/jbc.M202809200", "volume": "277", "author": "B He", "year": "2002", "unstructured": "He B, Lee LW, Minges JT, Wilson EM . (2002). Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J Biol Chem 277: 25631\u201325639.", "journal-title": "J Biol Chem"}, {"key": "BF1210955_CR20", "doi-asserted-by": "publisher", "first-page": "23691", "DOI": "10.1074/jbc.M211908200", "volume": "278", "author": "CL Hsu", "year": "2003", "unstructured": "Hsu CL, Chen YL, Yeh S, Ting HJ, Hu YC, Lin H et al. (2003). The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. J Biol Chem 278: 23691\u201323698.", "journal-title": "J Biol Chem"}, {"key": "BF1210955_CR21", "doi-asserted-by": "publisher", "first-page": "33438", "DOI": "10.1074/jbc.M401781200", "volume": "279", "author": "Y Hu", "year": "2004", "unstructured": "Hu Y, Yeh S, Yeh S, Sampson E, Huang J, Li P et al. (2004). Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. J Biol Chem 279: 33438\u201333446.", "journal-title": "J Biol Chem"}, {"key": "BF1210955_CR22", "doi-asserted-by": "publisher", "first-page": "E274", "DOI": "10.1371/journal.pbio.0020274", "volume": "2", "author": "E Hur", "year": "2004", "unstructured": "Hur E, Pfaff SJ, Payne ES, Gron H, Buehrer BM, Fletterick RJ . (2004). Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol 2: E274.", "journal-title": "PLoS Biol"}, {"key": "BF1210955_CR23", "doi-asserted-by": "publisher", "first-page": "232", "DOI": "10.1093/emboj/17.1.232", "volume": "17", "author": "E Kalkhoven", "year": "1998", "unstructured": "Kalkhoven E, Valentine JE, Heery DM, Parker MG . (1998). Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J 17: 232\u2013243.", "journal-title": "EMBO J"}, {"key": "BF1210955_CR24", "doi-asserted-by": "publisher", "first-page": "2633", "DOI": "10.1210/me.2004-0245", "volume": "18", "author": "Z Kang", "year": "2004", "unstructured": "Kang Z, Janne OA, Palvimo JJ . (2004). Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol 18: 2633\u20132648.", "journal-title": "Mol Endocrinol"}, {"key": "BF1210955_CR25", "doi-asserted-by": "publisher", "first-page": "1201", "DOI": "10.1210/me.2005-0309", "volume": "20", "author": "D Kazmin", "year": "2006", "unstructured": "Kazmin D, Prytkova T, Cook CE, Wolfinger R, Chu TM, Beratan D et al. (2006). Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators. Mol Endocrinol 20: 1201\u20131217.", "journal-title": "Mol Endocrinol"}, {"key": "BF1210955_CR26", "doi-asserted-by": "publisher", "first-page": "440", "DOI": "10.1210/mend.13.3.0255", "volume": "13", "author": "JA Kemppainen", "year": "1999", "unstructured": "Kemppainen JA, Langley E, Wong CI, Bobseine K, Kelce WR, Wilson EM . (1999). Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol Endocrinol 13: 440\u2013454.", "journal-title": "Mol Endocrinol"}, {"key": "BF1210955_CR27", "unstructured": "Li J, Zhang D, Fu J, Huang Z, Wong J . (2007). Structural and functional analysis of androgen receptor in chromatin. Mol Endocrinol; e-pub ahead of print.", "DOI": "10.1210/me.2006-0221", "doi-asserted-by": "crossref"}, {"key": "BF1210955_CR28", "doi-asserted-by": "publisher", "first-page": "1467", "DOI": "10.1016/S0002-9440(10)64422-7", "volume": "161", "author": "P Li", "year": "2002", "unstructured": "Li P, Yu X, Ge K, Melamed J, Roeder RG, Wang Z . (2002). Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol 161: 1467\u20131474.", "journal-title": "Am J Pathol"}, {"key": "BF1210955_CR29", "doi-asserted-by": "publisher", "first-page": "3763", "DOI": "10.1128/MCB.23.11.3763-3773.2003", "volume": "23", "author": "X Li", "year": "2003", "unstructured": "Li X, Wong J, Tsai SY, Tsai MJ, O\u2019Malley BW . (2003). Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol Cell Biol 23: 3763\u20133773.", "journal-title": "Mol Cell Biol"}, {"key": "BF1210955_CR30", "doi-asserted-by": "publisher", "first-page": "1032", "DOI": "10.1158/1078-0432.CCR-0990-3", "volume": "10", "author": "M Linja", "year": "2004", "unstructured": "Linja M, Porkka K, Kang Z, Savinainen K, Janne O, Tammela T et al. (2004). Expression of androgen receptor coregulators in prostate cancer. Clin Cancer Res 10: 1032\u20131040.", "journal-title": "Clin Cancer Res"}, {"key": "BF1210955_CR31", "first-page": "3550", "volume": "61", "author": "MJ Linja", "year": "2001", "unstructured": "Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T . (2001). Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 61: 3550\u20133555.", "journal-title": "Cancer Res"}, {"key": "BF1210955_CR32", "first-page": "4511", "volume": "57", "author": "S Lu", "year": "1997", "unstructured": "Lu S, Tsai S, Tsai M . (1997). Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res 57: 4511\u20134516.", "journal-title": "Cancer Res"}, {"key": "BF1210955_CR33", "doi-asserted-by": "publisher", "first-page": "1391", "DOI": "10.1002/pros.20427", "volume": "66", "author": "H Maki", "year": "2006", "unstructured": "Maki H, Waltering K, Wallen M, Martikainen P, Tammela T, van Weerden W et al. (2006). Screening of genetic and expression alterations of SRC1 gene in prostate cancer. Prostate 66: 1391\u20131398.", "journal-title": "Prostate"}, {"key": "BF1210955_CR34", "first-page": "944", "volume": "60", "author": "M Marcelli", "year": "2000", "unstructured": "Marcelli M, Ittmann M, Mariani S, Sutherland R, Nigam R, Murthy L et al. (2000). Androgen receptor mutations in prostate cancer. Cancer Res 60: 944\u2013949.", "journal-title": "Cancer Res"}, {"key": "BF1210955_CR35", "doi-asserted-by": "publisher", "first-page": "26164", "DOI": "10.1074/jbc.M004571200", "volume": "275", "author": "PM Matias", "year": "2000", "unstructured": "Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S et al. (2000). Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 275: 26164\u201326171.", "journal-title": "J Biol Chem"}, {"key": "BF1210955_CR36", "first-page": "2317", "volume": "60", "author": "S McDonald", "year": "2000", "unstructured": "McDonald S, Brive L, Agus DB, Scher HI, Ely KR . (2000). Ligand responsiveness in human prostate cancer: structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors. Cancer Res 60: 2317\u20132322.", "journal-title": "Cancer Res"}, {"key": "BF1210955_CR37", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1677/erc.0.0110281", "volume": "11", "author": "IJ McEwan", "year": "2004", "unstructured": "McEwan IJ . (2004). Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain. Endocr Relat Cancer 11: 281\u2013293.", "journal-title": "Endocr Relat Cancer"}, {"key": "BF1210955_CR38", "first-page": "321", "volume": "20", "author": "NJ McKenna", "year": "1999", "unstructured": "McKenna NJ, Lanz RB, O\u2019Malley BW . (1999). Nuclear receptor coregulators: cellular and molecular biology. Endocrine Rev 20: 321\u2013344.", "journal-title": "Endocrine Rev"}, {"key": "BF1210955_CR39", "doi-asserted-by": "publisher", "first-page": "192", "DOI": "10.1002/pros.10229", "volume": "56", "author": "C Mestayer", "year": "2003", "unstructured": "Mestayer C, Blanchere M, Jaubert F, Dufour B, Mowszowicz I . (2003). Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines. Prostate 56: 192\u2013200.", "journal-title": "Prostate"}, {"key": "BF1210955_CR40", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1016/S0092-8674(03)00934-6", "volume": "115", "author": "R Metivier", "year": "2003", "unstructured": "Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M et al. (2003). Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751\u2013763.", "journal-title": "Cell"}, {"key": "BF1210955_CR41", "doi-asserted-by": "publisher", "first-page": "7379", "DOI": "10.1073/pnas.95.13.7379", "volume": "95", "author": "H Miyamoto", "year": "1998", "unstructured": "Miyamoto H, Yeh S, Wilding G, Chang C . (1998). Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci USA 95: 7379\u20137384.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF1210955_CR42", "doi-asserted-by": "publisher", "first-page": "11890", "DOI": "10.1073/pnas.182376299", "volume": "99", "author": "PS Nelson", "year": "2002", "unstructured": "Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J et al. (2002). The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 99: 11890\u201311895.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF1210955_CR43", "doi-asserted-by": "publisher", "first-page": "683", "DOI": "10.1021/bi061321b", "volume": "46", "author": "MS Ozers", "year": "2007", "unstructured": "Ozers MS, Marks BD, Gowda K, Kupcho KR, Ervin KM, De Rosier T et al. (2007). The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Biochemistry 46: 683\u2013695.", "journal-title": "Biochemistry"}, {"key": "BF1210955_CR44", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1677/erc.0.0110117", "volume": "11", "author": "SM Powell", "year": "2004", "unstructured": "Powell SM, Christiaens V, Voulgaraki D, Waxman J, Claessens F, Bevan CL . (2004). Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate. Endocr Relat Cancer 11: 117\u2013130.", "journal-title": "Endocr Relat Cancer"}, {"key": "BF1210955_CR45", "doi-asserted-by": "publisher", "first-page": "6071", "DOI": "10.1093/emboj/20.21.6071", "volume": "20", "author": "I Rogatsky", "year": "2001", "unstructured": "Rogatsky I, Zarember KA, Yamamoto KR . (2001). Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J 20: 6071\u20136083.", "journal-title": "EMBO J"}, {"key": "BF1210955_CR46", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1517/13543784.15.4.377", "volume": "15", "author": "S Segal", "year": "2006", "unstructured": "Segal S, Narayanan R, Dalton JT . (2006). Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery. Expert Opin Investig Drugs 15: 377\u2013387.", "journal-title": "Expert Opin Investig Drugs"}, {"key": "BF1210955_CR47", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1002/ijc.10495", "volume": "100", "author": "K Steketee", "year": "2002", "unstructured": "Steketee K, Timmerman L, Ziel-van der Made AC, Doesburg P, Brinkmann AO, Trapman J . (2002). Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer. Int J Cancer 100: 309\u2013317.", "journal-title": "Int J Cancer"}, {"key": "BF1210955_CR48", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1038/ncponc0765", "volume": "4", "author": "ME Taplin", "year": "2007", "unstructured": "Taplin ME . (2007). Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Nat Clin Pract Oncol 4: 236\u2013244.", "journal-title": "Nat Clin Pract Oncol"}, {"key": "BF1210955_CR49", "doi-asserted-by": "publisher", "first-page": "1393", "DOI": "10.1056/NEJM199505253322101", "volume": "332", "author": "ME Taplin", "year": "1995", "unstructured": "Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK et al. (1995). Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332: 1393\u20131398.", "journal-title": "N Engl J Med"}, {"key": "BF1210955_CR50", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1016/S0014-5793(99)00845-5", "volume": "455", "author": "W Ulrix", "year": "1999", "unstructured": "Ulrix W, Swinnen JV, Heyns W, Verhoeven G . (1999). The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett 455: 23\u201326.", "journal-title": "FEBS Lett"}, {"key": "BF1210955_CR51", "doi-asserted-by": "publisher", "first-page": "19407", "DOI": "10.1074/jbc.M602567200", "volume": "281", "author": "DJ van de Wijngaart", "year": "2006", "unstructured": "van de Wijngaart DJ, van Royen ME, Hersmus R, Pike AC, Houtsmuller AB, Jenster G et al. (2006). Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. J Biol Chem 281: 19407\u201319416.", "journal-title": "J Biol Chem"}, {"key": "BF1210955_CR52", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1016/0960-0760(94)90277-1", "volume": "49", "author": "J Veldscholte", "year": "1994", "unstructured": "Veldscholte J, Berrevoets CA, Mulder E . (1994). Studies on the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol 49: 341\u2013346.", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "BF1210955_CR53", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1016/S1096-7192(03)00003-9", "volume": "78", "author": "G Verrijdt", "year": "2003", "unstructured": "Verrijdt G, Haelens A, Claessens F . (2003). Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab 78: 175\u2013185.", "journal-title": "Mol Genet Metab"}, {"key": "BF1210955_CR54", "doi-asserted-by": "publisher", "first-page": "87", "DOI": "10.1038/nsb0196-87", "volume": "3", "author": "J-M Wurtz", "year": "1996", "unstructured": "Wurtz J-M, Bourguet W, Renaud J-P, Vivat V, Chambon P, Moras D et al. (1996). A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3: 87\u201394.", "journal-title": "Nat Struct Biol"}, {"key": "BF1210955_CR55", "doi-asserted-by": "publisher", "first-page": "1922", "DOI": "10.1126/science.279.5358.1922", "volume": "279", "author": "J Xu", "year": "1998", "unstructured": "Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai M-J, O\u2019Malley BW . (1998). Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279: 1922\u20131925.", "journal-title": "Science"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1210955.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1210955", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1210955.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T11:34:31Z", "timestamp": 1555587271000}, "score": 29.658699, "issued": {"date-parts": [[2007, 11, 26]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2008, 5]]}, "issue": "21"}, "alternative-id": ["BF1210955"], "URL": "http://dx.doi.org/10.1038/sj.onc.1210955", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T20:37:30Z", "timestamp": 1574368650657}, "reference-count": 72, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 4, 1]], "date-time": "2008-04-01T00:00:00Z", "timestamp": 1207008000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Best Practice & Research Clinical Endocrinology & Metabolism"], "published-print": {"date-parts": [[2008, 4]]}, "DOI": "10.1016/j.beem.2008.01.009", "type": "journal-article", "created": {"date-parts": [[2008, 5, 8]], "date-time": "2008-05-08T14:08:31Z", "timestamp": 1210255711000}, "page": "357-372", "source": "Crossref", "is-referenced-by-count": 24, "title": ["A role for the androgen-receptor in clinically localized and advanced prostate cancer"], "prefix": "10.1016", "volume": "22", "author": [{"given": "James L.", "family": "Mohler", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Best Practice & Research Clinical Endocrinology & Metabolism"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1521690X08000109?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1521690X08000109?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 11]], "date-time": "2019-05-11T05:43:06Z", "timestamp": 1557553386000}, "score": 29.600042, "issued": {"date-parts": [[2008, 4]]}, "references-count": 72, "journal-issue": {"published-print": {"date-parts": [[2008, 4]]}, "issue": "2"}, "alternative-id": ["S1521690X08000109"], "URL": "http://dx.doi.org/10.1016/j.beem.2008.01.009", "ISSN": ["1521-690X"], "issn-type": [{"value": "1521-690X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T06:49:44Z", "timestamp": 1575182984470}, "publisher-location": "New York, NY", "reference-count": 57, "publisher": "Springer New York", "isbn-type": [{"value": "9781461461814", "type": "print"}, {"value": "9781461461821", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1007/978-1-4614-6182-1_1", "type": "book-chapter", "created": {"date-parts": [[2013, 2, 15]], "date-time": "2013-02-15T17:36:25Z", "timestamp": 1360949785000}, "page": "1-11", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Roles of Androgen Receptor Coregulators and Cell Signaling in the Regulation of Androgen-Responsive Genes"], "prefix": "10.1007", "author": [{"given": "Irina U.", "family": "Agoulnik", "sequence": "first", "affiliation": []}, {"given": "Nancy L.", "family": "Weigel", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2013, 1, 28]]}, "reference": [{"key": "1_CR00011", "doi-asserted-by": "publisher", "first-page": "37219", "DOI": "10.1074/jbc.274.52.37219", "volume": "274", "author": "B He", "year": "1999", "unstructured": "He B, Kemppainen JA, Voegel JJ, Gronemeyer H, Wilson EM (1999) Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J Biol Chem 274:37219\u201337225", "journal-title": "J Biol Chem"}, {"key": "1_CR00012", "doi-asserted-by": "publisher", "first-page": "1262", "DOI": "10.1038/nature03672", "volume": "435", "author": "DB Seligson", "year": "2005", "unstructured": "Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435:1262\u20131266", "journal-title": "Nature"}, {"key": "1_CR00013", "doi-asserted-by": "publisher", "first-page": "1354", "DOI": "10.1126/science.270.5240.1354", "volume": "270", "author": "SA Onate", "year": "1995", "unstructured": "Onate SA, Tsai SY, Tsai MJ, O\u2019Malley BW (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354\u20131357", "journal-title": "Science"}, {"key": "1_CR00014", "doi-asserted-by": "publisher", "first-page": "569", "DOI": "10.1016/S0092-8674(00)80516-4", "volume": "90", "author": "H Chen", "year": "1997", "unstructured": "Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569\u2013580", "journal-title": "Cell"}, {"key": "1_CR00015", "doi-asserted-by": "publisher", "first-page": "194", "DOI": "10.1038/38304", "volume": "389", "author": "TE Spencer", "year": "1997", "unstructured": "Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ et al (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194\u2013198", "journal-title": "Nature"}, {"key": "1_CR00016", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1016/j.ccr.2010.05.026", "volume": "18", "author": "BS Taylor", "year": "2010", "unstructured": "Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B et al (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18:11\u201322", "journal-title": "Cancer Cell"}, {"key": "1_CR00017", "doi-asserted-by": "publisher", "first-page": "10594", "DOI": "10.1158/0008-5472.CAN-06-1023", "volume": "66", "author": "IU Agoulnik", "year": "2006", "unstructured": "Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE 3rd, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM et al (2006) Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res 66:10594\u201310602", "journal-title": "Cancer Res"}, {"key": "1_CR00018", "first-page": "4315", "volume": "61", "author": "CW Gregory", "year": "2001", "unstructured": "Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS, Wilson EM (2001) A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61:4315\u20134319", "journal-title": "Cancer Res"}, {"key": "1_CR00019", "doi-asserted-by": "publisher", "first-page": "965", "DOI": "10.1126/science.277.5328.965", "volume": "277", "author": "SL Anzick", "year": "1997", "unstructured": "Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965\u2013968", "journal-title": "Science"}, {"key": "1_CR000110", "doi-asserted-by": "publisher", "first-page": "5460", "DOI": "10.1158/0008-5472.CAN-08-0955", "volume": "68", "author": "J Yan", "year": "2008", "unstructured": "Yan J, Erdem H, Li R, Cai Y, Ayala G, Ittmann M, Yu-Lee LY, Tsai SY, Tsai MJ (2008) Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res 68:5460\u20135468", "journal-title": "Cancer Res"}, {"key": "1_CR000111", "doi-asserted-by": "crossref", "first-page": "7976", "DOI": "10.1158/0008-5472.CAN-04-4076", "volume": "65", "author": "HJ Zhou", "year": "2005", "unstructured": "Zhou HJ, Yan J, Luo W, Ayala G, Lin SH, Erdem H, Ittmann M, Tsai SY, Tsai MJ (2005) SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 65:7976\u20137983", "journal-title": "Cancer Res"}, {"key": "1_CR000112", "doi-asserted-by": "publisher", "first-page": "669", "DOI": "10.1016/j.steroids.2009.02.007", "volume": "74", "author": "IU Agoulnik", "year": "2009", "unstructured": "Agoulnik IU, Weigel NL (2009) Coactivator selective regulation of androgen receptor activity. Steroids 74:669\u2013674", "journal-title": "Steroids"}, {"key": "1_CR000113", "doi-asserted-by": "publisher", "first-page": "11039", "DOI": "10.1158/0008-5472.CAN-06-2442", "volume": "66", "author": "J Yan", "year": "2006", "unstructured": "Yan J, Yu CT, Ozen M, Ittmann M, Tsai SY, Tsai MJ (2006) Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res 66:11039\u201311046", "journal-title": "Cancer Res"}, {"key": "1_CR000114", "doi-asserted-by": "publisher", "first-page": "7742", "DOI": "10.1128/MCB.23.21.7742-7755.2003", "volume": "23", "author": "G Zhou", "year": "2003", "unstructured": "Zhou G, Hashimoto Y, Kwak I, Tsai SY, Tsai MJ (2003) Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol 23:7742\u20137755", "journal-title": "Mol Cell Biol"}, {"key": "1_CR000115", "doi-asserted-by": "publisher", "first-page": "4350", "DOI": "10.1038/onc.2011.151", "volume": "30", "author": "C Li", "year": "2011", "unstructured": "Li C, Ao J, Fu J, Lee DF, Xu J, Lonard D, O\u2019Malley BW (2011) Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1. Oncogene 30:4350\u20134364", "journal-title": "Oncogene"}, {"key": "1_CR000116", "doi-asserted-by": "publisher", "first-page": "685", "DOI": "10.1038/ng.2279", "volume": "44", "author": "CE Barbieri", "year": "2012", "unstructured": "Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N et al (2012) Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 44:685\u2013689", "journal-title": "Nat Genet"}, {"key": "1_CR000117", "doi-asserted-by": "crossref", "first-page": "7959", "DOI": "10.1158/0008-5472.CAN-04-3541", "volume": "65", "author": "IU Agoulnik", "year": "2005", "unstructured": "Agoulnik IU, Vaid A, Bingman WE 3rd, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NL (2005) Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res 65:7959\u20137967", "journal-title": "Cancer Res"}, {"key": "1_CR000118", "doi-asserted-by": "publisher", "first-page": "20853", "DOI": "10.1074/jbc.M000660200", "volume": "275", "author": "M Fu", "year": "2000", "unstructured": "Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML, Pestell RG (2000) p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem 275:20853\u201320860", "journal-title": "J Biol Chem"}, {"key": "1_CR000119", "doi-asserted-by": "publisher", "first-page": "8563", "DOI": "10.1128/MCB.23.23.8563-8575.2003", "volume": "23", "author": "M Fu", "year": "2003", "unstructured": "Fu M, Rao M, Wang C, Sakamaki T, Wang J, Di Vizio D, Zhang X, Albanese C, Balk S, Chang C et al (2003) Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 23:8563\u20138575", "journal-title": "Mol Cell Biol"}, {"key": "1_CR000120", "doi-asserted-by": "publisher", "first-page": "4000", "DOI": "10.1074/jbc.M111.300194", "volume": "287", "author": "I Ianculescu", "year": "2012", "unstructured": "Ianculescu I, Wu DY, Siegmund KD, Stallcup MR (2012) Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells. J Biol Chem 287:4000\u20134013", "journal-title": "J Biol Chem"}, {"key": "1_CR000121", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H", "volume": "41", "author": "DE Drachenberg", "year": "1999", "unstructured": "Drachenberg DE, Elgamal AA, Rowbotham R, Peterson M, Murphy GP (1999) Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate 41:127\u2013133", "journal-title": "Prostate"}, {"key": "1_CR000122", "doi-asserted-by": "publisher", "first-page": "246", "DOI": "10.1016/1078-1439(96)00012-9", "volume": "1", "author": "N Hoosein", "year": "1995", "unstructured": "Hoosein N, Abdul M, McCabe R, Gero E, Deftos L, Banks M, Hodges S, Finn L, Logothetis C (1995) Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer. Urol Oncol 1:246\u2013251", "journal-title": "Urol Oncol"}, {"key": "1_CR000123", "first-page": "5632", "volume": "62", "author": "JD Debes", "year": "2002", "unstructured": "Debes JD, Schmidt LJ, Huang H, Tindall DJ (2002) p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6. Cancer Res 62:5632\u20135636", "journal-title": "Cancer Res"}, {"key": "1_CR000124", "doi-asserted-by": "publisher", "first-page": "7938", "DOI": "10.1158/0008-5472.CAN-08-0932", "volume": "68", "author": "EL Clark", "year": "2008", "unstructured": "Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, Fleming S, Heer R, Gaughan L, Leung HY, Elliott DJ et al (2008) The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res 68:7938\u20137946", "journal-title": "Cancer Res"}, {"key": "1_CR000125", "doi-asserted-by": "publisher", "first-page": "31136", "DOI": "10.1074/jbc.M305153200", "volume": "278", "author": "IU Agoulnik", "year": "2003", "unstructured": "Agoulnik IU, Krause WC, Bingman WE 3rd, Rahman HT, Amrikachi M, Ayala GE, Weigel NL (2003) Repressors of androgen and progesterone receptor action. J Biol Chem 278:31136\u201331148", "journal-title": "J Biol Chem"}, {"key": "1_CR000126", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.1016/S1097-2765(02)00471-9", "volume": "9", "author": "Y Shang", "year": "2002", "unstructured": "Shang Y, Myers M, Brown M (2002) Formation of the androgen receptor transcription complex. Mol Cell 9:601\u2013610", "journal-title": "Mol Cell"}, {"key": "1_CR000127", "doi-asserted-by": "publisher", "first-page": "9316", "DOI": "10.1158/0008-5472.CAN-06-1902", "volume": "66", "author": "J Yu", "year": "2006", "unstructured": "Yu J, Palmer C, Alenghat T, Li Y, Kao G, Lazar MA (2006) The corepressor silencing mediator for retinoid and thyroid hormone receptor facilitates cellular recovery from DNA double-strand breaks. Cancer Res 66:9316\u20139322", "journal-title": "Cancer Res"}, {"key": "1_CR000128", "doi-asserted-by": "publisher", "first-page": "6116", "DOI": "10.1128/MCB.00900-07", "volume": "27", "author": "F Furuya", "year": "2007", "unstructured": "Furuya F, Guigon CJ, Zhao L, Lu C, Hanover JA, Cheng SY (2007) Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Mol Cell Biol 27:6116\u20136126", "journal-title": "Mol Cell Biol"}, {"key": "1_CR000129", "doi-asserted-by": "publisher", "first-page": "681", "DOI": "10.1101/gad.1773109", "volume": "23", "author": "S Ghisletti", "year": "2009", "unstructured": "Ghisletti S, Huang W, Jepsen K, Benner C, Hardiman G, Rosenfeld MG, Glass CK (2009) Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 23:681\u2013693", "journal-title": "Genes Dev"}, {"key": "1_CR000130", "doi-asserted-by": "publisher", "first-page": "70", "DOI": "10.1016/j.mce.2011.07.004", "volume": "352", "author": "D Gioeli", "year": "2012", "unstructured": "Gioeli D, Paschal BM (2012) Post-translational modification of the androgen receptor. Mol Cell Endocrinol 352:70\u201378", "journal-title": "Mol Cell Endocrinol"}, {"key": "1_CR000131", "doi-asserted-by": "publisher", "first-page": "29304", "DOI": "10.1074/jbc.M204131200", "volume": "277", "author": "D Gioeli", "year": "2002", "unstructured": "Gioeli D, Ficarro SB, Kwiek JJ, Aaronson D, Hancock M, Catling AD, White FM, Christian RE, Settlage RE, Shabanowitz J et al (2002) Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 277:29304\u201329314", "journal-title": "J Biol Chem"}, {"key": "1_CR000132", "doi-asserted-by": "publisher", "first-page": "2267", "DOI": "10.1210/me.2010-0238", "volume": "24", "author": "V Gordon", "year": "2010", "unstructured": "Gordon V, Bhadel S, Wunderlich W, Zhang J, Ficarro SB, Mollah SA, Shabanowitz J, Hunt DF, Xenarios I, Hahn WC et al (2010) CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation. Mol Endocrinol 24:2267\u20132280", "journal-title": "Mol Endocrinol"}, {"key": "1_CR000133", "doi-asserted-by": "publisher", "first-page": "8571", "DOI": "10.1074/jbc.M111.325290", "volume": "287", "author": "S Chen", "year": "2012", "unstructured": "Chen S, Gulla S, Cai C, Balk SP (2012) Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation. J Biol Chem 287:8571\u20138583", "journal-title": "J Biol Chem"}, {"key": "1_CR000134", "doi-asserted-by": "publisher", "first-page": "4996", "DOI": "10.1158/0008-5472.CAN-05-2796", "volume": "66", "author": "EC Lee", "year": "2006", "unstructured": "Lee EC, Frolov A, Li R, Ayala G, Greenberg NM (2006) Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 66:4996\u20135002", "journal-title": "Cancer Res"}, {"key": "1_CR000135", "doi-asserted-by": "publisher", "first-page": "33045", "DOI": "10.1074/jbc.M110.121129", "volume": "285", "author": "SK Shu", "year": "2010", "unstructured": "Shu SK, Liu Q, Coppola D, Cheng JQ (2010) Phosphorylation and activation of androgen receptor by Aurora-A. J Biol Chem 285:33045\u201333053", "journal-title": "J Biol Chem"}, {"key": "1_CR000136", "doi-asserted-by": "publisher", "first-page": "6572", "DOI": "10.1158/1078-0432.CCR-04-0477", "volume": "10", "author": "G Ayala", "year": "2004", "unstructured": "Ayala G, Thompson T, Yang G, Frolov A, Li R, Scardino P, Ohori M, Wheeler T, Harper W (2004) High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clin Cancer Res 10:6572\u20136578", "journal-title": "Clin Cancer Res"}, {"key": "1_CR000137", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1002/mc.20121", "volume": "44", "author": "H Miyamoto", "year": "2005", "unstructured": "Miyamoto H, Altuwaijri S, Cai Y, Messing EM, Chang C (2005) Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer. Mol Carcinog 44:1\u201310", "journal-title": "Mol Carcinog"}, {"key": "1_CR000138", "doi-asserted-by": "publisher", "first-page": "591", "DOI": "10.2174/156800907781662248", "volume": "7", "author": "Y Wang", "year": "2007", "unstructured": "Wang Y, Kreisberg JI, Ghosh PM (2007) Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer. Curr Cancer Drug Targets 7:591\u2013604", "journal-title": "Curr Cancer Drug Targets"}, {"key": "1_CR000139", "doi-asserted-by": "publisher", "first-page": "50902", "DOI": "10.1074/jbc.M300676200", "volume": "278", "author": "HK Lin", "year": "2003", "unstructured": "Lin HK, Hu YC, Yang L, Altuwaijri S, Chen YT, Kang HY, Chang C (2003) Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers. J Biol Chem 278:50902\u201350907", "journal-title": "J Biol Chem"}, {"key": "1_CR000140", "doi-asserted-by": "publisher", "first-page": "7200", "DOI": "10.1073/pnas.121173298", "volume": "98", "author": "HK Lin", "year": "2001", "unstructured": "Lin HK, Yeh S, Kang HY, Chang C (2001) Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc Natl Acad Sci U S A 98:7200\u20137205", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "1_CR000141", "doi-asserted-by": "publisher", "first-page": "40916", "DOI": "10.1074/jbc.M508442200", "volume": "280", "author": "SS Taneja", "year": "2005", "unstructured": "Taneja SS, Ha S, Swenson NK, Huang HY, Lee P, Melamed J, Shapiro E, Garabedian MJ, Logan SK (2005) Cell-specific regulation of androgen receptor phosphorylation in vivo. J Biol Chem 280:40916\u201340924", "journal-title": "J Biol Chem"}, {"key": "1_CR000142", "first-page": "6841", "volume": "60", "author": "Y Wen", "year": "2000", "unstructured": "Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH, Hung MC (2000) HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res 60:6841\u20136845", "journal-title": "Cancer Res"}, {"key": "1_CR000143", "doi-asserted-by": "publisher", "first-page": "29584", "DOI": "10.1074/jbc.M703310200", "volume": "282", "author": "B Cinar", "year": "2007", "unstructured": "Cinar B, Mukhopadhyay NK, Meng G, Freeman MR (2007) Phosphoinositide 3-kinase-\u00adindependent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains. J Biol Chem 282:29584\u201329593", "journal-title": "J Biol Chem"}, {"key": "1_CR000144", "doi-asserted-by": "publisher", "first-page": "572", "DOI": "10.1158/0008-5472.CAN-10-2314", "volume": "71", "author": "MC Hodgson", "year": "2011", "unstructured": "Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, Ayala G, Ittmann MM, Weigel NL, Agoulnik IU (2011) Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res 71:572\u2013582", "journal-title": "Cancer Res"}, {"key": "1_CR000145", "doi-asserted-by": "publisher", "first-page": "575", "DOI": "10.1016/j.ccr.2011.04.008", "volume": "19", "author": "BS Carver", "year": "2011", "unstructured": "Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK, Le C, Koutcher J, Scher H et al (2011) Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 19:575\u2013586", "journal-title": "Cancer Cell"}, {"key": "1_CR000146", "doi-asserted-by": "publisher", "first-page": "1553", "DOI": "10.1158/1078-0432.CCR-09-2546", "volume": "16", "author": "S Minner", "year": "2010", "unstructured": "Minner S, Jessen B, Stiedenroth L, Burandt E, Kollermann J, Mirlacher M, Erbersdobler A, Eichelberg C, Fisch M, Brummendorf TH et al (2010) Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. Clin Cancer Res 16:1553\u20131560", "journal-title": "Clin Cancer Res"}, {"key": "1_CR000147", "doi-asserted-by": "crossref", "first-page": "5143", "DOI": "10.1128/MCB.19.7.5143", "volume": "19", "author": "MT Abreu-Martin", "year": "1999", "unstructured": "Abreu-Martin MT, Chari A, Palladino AA, Craft NA, Sawyers CL (1999) Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer. Mol Cell Biol 19:5143\u20135154", "journal-title": "Mol Cell Biol"}, {"key": "1_CR000148", "first-page": "279", "volume": "59", "author": "D Gioeli", "year": "1999", "unstructured": "Gioeli D, Mandell JW, Petroni GR, Frierson HF Jr, Weber MJ (1999) Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 59:279\u2013284", "journal-title": "Cancer Res"}, {"key": "1_CR000149", "doi-asserted-by": "publisher", "first-page": "2420", "DOI": "10.1210/me.2007-0481", "volume": "22", "author": "IU Agoulnik", "year": "2008", "unstructured": "Agoulnik IU, Bingman WE 3rd, Nakka M, Li W, Wang Q, Liu XS, Brown M, Weigel NL (2008) Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase. Mol Endocrinol 22:2420\u20132432", "journal-title": "Mol Endocrinol"}, {"key": "1_CR000150", "doi-asserted-by": "publisher", "first-page": "520", "DOI": "10.1002/ijc.22715", "volume": "121", "author": "AM Carey", "year": "2007", "unstructured": "Carey AM, Pramanik R, Nicholson LJ, Dew TK, Martin FL, Muir GH, Morris JD (2007) Ras-MEK-ERK signaling cascade regulates androgen receptor element-inducible gene transcription and DNA synthesis in prostate cancer cells. Int J Cancer 121:520\u2013527", "journal-title": "Int J Cancer"}, {"key": "1_CR000151", "doi-asserted-by": "publisher", "first-page": "7119", "DOI": "10.1074/jbc.M307649200", "volume": "279", "author": "CW Gregory", "year": "2004", "unstructured": "Gregory CW, Fei X, Ponguta LA, He B, Bill HM, French FS, Wilson EM (2004) Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J Biol Chem 279:7119\u20137130", "journal-title": "J Biol Chem"}, {"key": "1_CR000152", "doi-asserted-by": "publisher", "first-page": "5041", "DOI": "10.1128/MCB.20.14.5041-5047.2000", "volume": "20", "author": "J Font de Mora", "year": "2000", "unstructured": "Font de Mora J, Brown M (2000) AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20:5041\u20135047", "journal-title": "Mol Cell Biol"}, {"key": "1_CR000153", "doi-asserted-by": "publisher", "first-page": "4475", "DOI": "10.1074/jbc.275.6.4475", "volume": "275", "author": "BG Rowan", "year": "2000", "unstructured": "Rowan BG, Weigel NL, O\u2019Malley BW (2000) Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275:4475\u20134483", "journal-title": "J Biol Chem"}, {"key": "1_CR000154", "doi-asserted-by": "publisher", "first-page": "937", "DOI": "10.1016/j.molcel.2004.08.019", "volume": "15", "author": "RC Wu", "year": "2004", "unstructured": "Wu RC, Qin J, Yi P, Wong J, Tsai SY, Tsai MJ, O\u2019Malley BW (2004) Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 15:937\u2013949", "journal-title": "Mol Cell"}, {"key": "1_CR000155", "doi-asserted-by": "publisher", "first-page": "28787", "DOI": "10.1074/jbc.M110.134064", "volume": "285", "author": "A Sen", "year": "2010", "unstructured": "Sen A, O\u2019Malley K, Wang Z, Raj GV, Defranco DB, Hammes SR (2010) Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 285:28787\u201328795", "journal-title": "J Biol Chem"}, {"issue": "7", "key": "1_CR000156", "doi-asserted-by": "publisher", "first-page": "2469", "DOI": "10.1172/JCI62044", "volume": "122", "author": "A Sen", "year": "2012", "unstructured": "Sen A, De Castro I, Defranco DB, Deng FM, Melamed J, Kapur P, Raj GV, Rossi R, Hammes SR (2012) Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J Clin Invest 122(7):2469\u20132481", "journal-title": "J Clin Invest"}, {"key": "1_CR000157", "doi-asserted-by": "publisher", "first-page": "2810", "DOI": "10.1038/emboj.2012.112", "volume": "31", "author": "KR Chng", "year": "2012", "unstructured": "Chng KR, Chang CW, Tan SK, Yang C, Hong SZ, Sng NY, Cheung E (2012) A transcriptional repressor co-regulatory network governing androgen response in prostate cancers. EMBO J 31:2810\u20132823", "journal-title": "EMBO J"}], "container-title": ["Androgen-Responsive Genes in Prostate Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4614-6182-1_1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 11]], "date-time": "2019-05-11T07:40:06Z", "timestamp": 1557560406000}, "score": 29.572088, "issued": {"date-parts": [[2013]]}, "ISBN": ["9781461461814", "9781461461821"], "references-count": 57, "URL": "http://dx.doi.org/10.1007/978-1-4614-6182-1_1", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}